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There appears to be clear evidence of cognitive impairment in schizophrenia which is 
wide ranging and relatively stable throughout the illness. Both cognitive impairment and 
treatment response have been argued to be highly relevant in risk assessment and 
management of offenders. However, there does not appear to be any research in this area 
on mentally disordered offenders. It is on this basis that this study attempts to determine 




A cohort quantitative research design was used and the data were obtained via the 
administration of neuropsychological assessments and self-report measures. 
Neuropsychological data on attention, executive functioning, memory and IQ were 
matched with treatment gain scores for 114 male mentally disordered offenders. The 
participants were further matched according to the group treatments they had 
participated in resulting in five different groups.   
 
Results 
Univariate and bivariate analyses were used to explore the relationship between 
cognitive predictor variables and treatment gain scores. Variables that were significantly 
associated with treatment gain scores were further investigated using multiple regression 
analyses. Results indicated that for each group, cognitive variables such as attention and 
memory were significantly predictive of treatment gain scores. 
 
Conclusion 
The results indicate the need to consider cognitive impairment constructs such as 
attention, executive functioning, memory and IQ when determining appropriate 
interventions for mentally disorders offenders. Doing so may improve treatment 
responsivity and have a consequent impact on risk management and recidivism. The 
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research limitations are discussed in relation to the methodology used, and clinical 

































 1.1 Overview  
Information on the prevalence of cognitive impairment in schizophrenia is presented and 
the consequent impact of this in terms of behaviour. The role of cognitive deficits in 
treatment outcomes is discussed, followed by exploration of treatment options available 
for mentally disordered offenders such as Cognitive Behavioural Therapy (CBT). 
Consideration is given to the many potential factors influencing treatment responsivity 
in mentally disordered offenders. Finally, the importance of addressing cognitive 
impairment in schizophrenia in relation to risk management is discussed.  
 
 1.2 Recidivism Amongst Mentally Disordered Offenders (MDO’s) 
A ‘forensic’ patient or Mentally Disordered Offender can be described as a patient 
subject to compulsory measures under mental health legislation, who has a significant 
history of offending behaviour and/or represents a significant risk to others, requiring 
specialist 'forensic' expertise in their care and management (Langton, 2010). There 
appears to be a popular perception exacerbated by the media of the “dangerousness” of 
mentally disordered offenders (McGuire, 2000). This may in part be due to the typically 
complex presentation of MDO’s, who in conjunction with their offending behaviour, 
often present with multiple problems such as psychosis, substance misuse, personality 
disorder, and cognitive impairment (Forensic Mental Health Matrix Consultation Paper, 
2011). 
 
A retrospective analysis in the UK over a 38 year period illustrated that the number of 
murders committed by MDO’s has steadily declined. Nonetheless, there is evidence to 
suggest that certain types of mental illness pose greater risk. A study comparing rates of 
violence in patient and non-patient samples found that psychotic symptoms accounted 
for almost all of the difference between the two groups (Link & Stueve, 1993). The 
study specifically identified paranoid delusions where individuals feel threatened as 
most closely associated with the risk of violence. More recently this finding has also 
been supported by O’Kane and Bentall (2000) who stated that persecutory delusions and 
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command hallucinations increased the risk of violence.  Other factors associated with 
recidivism are having a diagnosis of personality disorder and being unmarried (Quinsey 
et al., 1975). This concurs with more recent research which found that anti-social 
personality disorder was associated with a greater risk of recidivism (Bonta et al., 1998). 
However, this meta-analytic review involving a sample of 15, 245 MDO’s, found that 
the most accurate predictors of recidivism were demographic or criminal history 
variables rather than clinical variables such as diagnoses. This finding appears to be 
consistent with other research indicating young age, previous convictions and a 
diagnosis of psychopathy are all predictors of recidivism in MDO’s (Buchanan, 1998). 
 
Research on patients discharged from maximum security hospitals in the UK (also 
known as ‘Special Hospitals’) illustrates lower rates of recidivism and readmission than 
what may be expected given the severity of the initial index offence, and when 
compared to offenders without mental disorders (McGuire, 2000). Nonetheless, the 
research cited above indicates that mentally disordered offenders suffering from 
psychotic symptoms such as paranoid and persecutory delusions pose a greater risk of 
re-offending.   
1.3 Treating Mentally Disordered Offenders 
This study was conducted in a maximum secure psychiatric hospital in Scotland 
responsible for the care and treatment of 134 (at the time of writing) mentally disordered 
offenders, the majority of whom have a diagnosis of schizophrenia (62.6%)(State 
Hospital Medical Records Data, 2010). Cognitive impairment is a common feature in 
major psychiatric disorders and is significantly related to treatment outcome (Green & 
Nuechterlein, 1999).  Given the high incidence of schizophrenia and other psychiatric 
disorders, combined with factors such as acquired brain injury and drug and alcohol 
misuse frequently evident in MDO’s, the research discussed previously would suggest a 
high level of cognitive impairment must exist within this patient population. Data from 
125 patients in maximum secure psychiatric care in Scotland who completed 
neuropsychological assessment indicated that 79% had an index score on the WAIS-III 
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that was within the borderline range i.e. between 70-79 where below 70 represents 
presence of a learning disability (O’Rourke, 2011). 
Effective treatments for all types of offenders i.e. with or without mental disorder, are 
important in terms of reducing risk of future reoffending, improving their quality of life 
and increasing the likelihood of early discharge (Fishbein et al., 2006). Treatments such 
as cognitive-behavioural therapy (CBT) are generally considered effective but a 
significant proportion of prison inmates do not respond well, display poor engagement, 
behavioural and emotional control problems, high attrition rates, and continued 
behavioural incidents resulting in future recidivism (Fishbein et al., 2006). A review on 
the use of offending behaviour programmes for people with mental health problems, 
revealed a modest overall effect on reducing recidivism with rates varying from 10% or 
less to 24%, dependent on factors such as gender, age and risk of re-offending 
(Sainsbury Centre for Mental Health, 2008). This is in comparison to reconviction rates 
for offenders without mental health problems which have been reported as 65% within 
two years of release (Rutherford & Duggan, 2007). It would therefore appear that 
effective treatment is crucial in order to avoid repetition of treatment and delayed 
discharge. 
 
1.4 Cognitive Behaviour Therapy (CBT) for Schizophrenia 
CBT can be described as a talking therapy that attempts to change thoughts and 
behaviour by developing a formulation of the individual’s difficulties, personal 
background and views of the world (Tai & Turkington, 2009). Beck (1979) stated that 
the key components of CBT were engagement with the patient, working together to 
develop a problem list and establishing clear goals for therapy. The emphasis of a joint 
collaborative approach to therapy was highlighted, particularly when developing a 
shared formulation or understanding of the person’s difficulties. Initially CBT for 
schizophrenia focused on behavioural change by improving coping mechanisms, 
compliance with medication and social and independent living skills (Weiden et al., 
1995). Behavioural strategies such as graded activity programmes were used to treat 
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negative symptoms (Miechenbaum & Cameron, 1973). The cognitive element in treating 
psychosis was later incorporated by highlighting the importance of the meaning or 
interpretation of events, and how biased information processing, increased attention to 
the perceived threat and avoidance behaviours can lead to the development of false 
beliefs (Tai & Turkington, 2009). Additional amendments to standard CBT have been 
made such as addressing the stigma of being labeled schizophrenic, and providing 
information on the number of other people who have similar experiences i.e. 
normalising.   
 
There is a significant evidence base for CBT in treating numerous disorders such as 
anxiety and depression as well as psychotic disorders such as schizophrenia (Kingdon & 
Turkington, 1994). Moderate effect sizes have been found in randomised controlled 
trials of CBT for schizophrenia, with gains in both positive and negative symptoms at 
the end of treatment and follow-up (Gould et al., 2001). However, CBT is less effective 
if the individual lacks insight into their mental health problems or delusional beliefs. 
Furthermore, comorbid presentations are less likely to benefit as these individuals are 
more difficult to engage and treat. A meta-analysis of CBT for schizophrenia found that 
acute presentations benefitted more than chronic presentations, indicating the difficulty 
treating more complex and longstanding cases (Zimmermann et al., 2005). As a result of 
the consistent evidence in support of CBT for schizophrenia, the National Institute of 
Clinical Excellence (NICE)(2002) recommend that CBT is routinely offered to patients 
with symptoms of schizophrenia. 
1.5 Psycho-education for Psychosis 
Other approaches for treating psychosis are psycho-education (PE) which has been 
described as a systematic didactic-psychotherapeutic intervention, designed to promote 
coping and inform patients and their relatives about the illness (Wiedemann et al., 
2003). It appears to be a widely used approach with a survey revealing 72% of 
institutions in Austria, Germany and Switzerland had used PE for schizophrenia, 
primarily with patients (Rummel-Kluge et al., 2006). A meta-analysis of randomized 
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controlled trials where PE was the main intervention for schizophrenia and other 
psychosis was conducted by Lincoln et al., (2007). The analysis compared 18 studies on 
factors such as relapse, symptoms and knowledge of illness, medication adherence and 
daily functioning in patients. The findings indicated that PE with patients alone did not 
produce significant results, but if families were included there was a medium effect for 
relapse and a small effect for knowledge of illness at post-treatment. There was not a 
significant effect of PE on medication adherence, symptoms, and functioning. The 
analysis concluded that involvement of families in PE was worthwhile as otherwise it 
appears that PE with patients alone is not effective. Possible explanations for this finding 
were that PE programmes are primarily delivered in a lecture style, meaning that 
patients with attention or memory difficulties may struggle to retain the information. 
This may be why a more interactive format using behavioural components has been 
found to produce better results (Zygmunt et al., 2002).  
 
1.6 Treatment Responsivity 
The concept of treatment responsivity appears to be a wide one and can encompass 
many features such as treatment gain, adherence and motivation. These features can be 
broken down further into individual factors such as preferred learning style and external 
factors such as group versus individual therapeutic work. However, for the purposes of 
this study the aim is to measure treatment gain as it is beyond the scope of this study to 
assess all possible facets of treatment responsivity. Nonetheless, the importance of these 
other aspects of treatment responsivity should be taken into consideration when 
attempting to assess treatment gain and adherence, and will therefore be explored in 
further detail. 
 
When reviewing “what works” with MDO’s the literature on general offenders offers 
much more information than that available on offenders with mental health problems. 
However, McGuire (2000) suggests that rather than viewing this as a significant issue, 
the numerous studies on people with mental health problems as well as research on 
offender populations offer an alternative. By utilising what we know about mental health 
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research and offending behaviour research it is possible to offer interventions that target 
both these aspects with MDO’s. In the offender literature, Andrews et al., (1986 & 
1990) identified four principles for successful rehabilitation of offenders. Their findings 
were based on analysis of programmes that demonstrated above average success in 
reducing recidivism. The first principle is based on risk and states that treatment should 
be matched to the level of risk the offender presents. This is based on previous research 
findings that low risk offenders respond better to minimal interventions and high risk 
offenders to intensive treatment. The next principle is based on need and distinguishes 
between criminogenic and non-criminogenic needs. The former are risk factors, which if 
they can be reduced, can decrease recidivism. Non-criminogenic factors might be 
depression or anxiety which may not necessarily have a significant impact on recidivism 
if changed. 
 
The third principle identified is responsivity and this states that methods of treatment 
should be matched to the preferred learning style of the offender. Matching therapists’ 
style to the individuals’ style combined with the style of intervention is crucial to 
treatment responsivity (Bonta, 1995). Therefore, being aware of an individual’s 
cognitive deficits would appear to be highly relevant when establishing their preferred 
learning style, and in turn maximising their treatment responsivity. The responsivity 
principle and other factors related to offender motivation are a neglected area of 
research, despite the fact that they are widely recognised as crucial in determining the 
success of treatment (Brown, 1996). 
 
The final principle states that following consideration of risk, need and treatment 
responsivity there is a need for professional judgement. This professional judgement 
principle recognises the need for clinical judgement to encompass all aspects of the 
individuals’ presentation when determining treatment options. 
 
Kennedy (2000) breaks down responsivity into three components which include 
matching the treatment approach to the learning style of the individual, the 
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characteristics of the therapist and patient, and matching the skills of the therapist with 
the treatment being delivered. The responsivity principle therefore states that these 
factors have a direct impact on treatment effectiveness and consequently on recidivism. 
To highlight this point the relationship between the therapist and patient has been 
described as a key factor in response to treatment (Medalia & Choi, 2009). This is vitally 
important as treatment programmes may fail not because of poor therapists or 
programme content, but because the individual’s responsivity factors, such as cognitive 
impairments, have not been addressed.  
 
Responsivity factors can also be broken down into internal and external factors 
(Kennedy, 2000). Internal factors are those specific to the individual such as motivation, 
personality characteristics, intellectual capabilities and demographic variables such as 
age and gender. External factors can range from those related to the therapist i.e. 
personality characteristics, and the setting in which treatment is conducted, for example, 
the community or a maximum security hospital and individual versus group work. The 
importance of factors such as therapist qualification, treatment intensity, patient 
motivation and work habits have been highlighted as moderating factors which can 
distinguish those who benefit on neuropsychological outcome measures (Medalia & 
Richardson, 2005). To highlight this point research has shown no significant difference 
between seven or 33 sessions of group cognitive remediation, indicating the role of 
various other factors affecting treatment response (Krabbendam & Aleman, 2003). 
 
Kennedy (2000) states that it may be helpful to assess treatment readiness, motivation 
and treatability in an objective manner in order to determine the most appropriate 
treatment option. Rather than simply asking the offender’s opinion and basing your 
opinion on their self-report, several factors may be relevant to consider in an assessment. 
Items might include whether or not the offender has the support of significant others, is 
able to express their feelings, has previously engaged in treatment and what progress 
they made, is motivated for treatment and able to set goals and recognises they have a 
problem. Further considerations might be the offenders’ awareness of the emotional 
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demands of treatment, their sense of self-efficacy in making changes and their view on 
the therapist (Kennedy, 1999).    
 
1.6.1 Theoretical Underpinnings of Treatment Responsivity  
Serin (1998) proposes in his Treatment Responsivity Model that there should be pre-
treatment appraisal of an individual’s level of risk and consequent needs, assessment of 
treatment motivation and treatment gain. By combining treatment motivation and 
treatment gain he argues this can be considered as treatment responsivity. This model 
states that low motivation and low treatment gain indicate poor treatment responsivity 
and vice versa. By determining an individuals’ responsivity level this can then be used in 
conjunction with their risk assessment to develop appropriate risk management plans. 
This is highly relevant in relation to reducing recidivism rates as mentioned previously. 
This model stems from the work of Andrews et al., (1990) discussed previously in 
section 1.6 which became known as the Risk-Need-Responsivity (RNR) model. The 
principles they outlined for effective rehabilitation of offenders have had a significant 
influence on practice, theory and policy (Ward, Melser & Yates, 2007). Interventions for 
offenders that follow these principles are associated with a significant decrease in 
recidivism; and those which do not have minimal reduction in recidivism rates, and in 
certain situations, have increased recidivism (Andrews & Bonta, 2010).    
 
In order to understand the variability in response to treatment Schunk and Zimmerman 
(2008) proposed the Reciprocal Interactions Model which considers how people learn. 
This model posits that learning occurs through the interaction of three factors: 
instructional techniques, motivation and cognitive ability. Instructional techniques relate 
to the importance of the method in which treatment is delivered, and the type of 
treatment that is utilised. Instructional factors that may impact on motivation are 
personalisation, choice and contextualisation (Medalia & Choi, 2009). Personalisation 
refers to modifying a learning activity to fit with the specific interests of an individual, 
for example using football related tasks and words when teaching problem solving skills 
to an individual who likes football. A further component of personalisation may be 
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getting the person to assume a specific role in a task or signing in by name. Choice 
involves giving the learner some control of the task by perhaps choosing the difficulty 
level, or which task they will perform as opposed to being told what to do. This may be 
particularly relevant if using computer based programmes where the element of 
individual choice is more easily achievable. Contextualisation is when the material is put 
into a real life context so that it is more easily understood and relevant to the individual 
rather than an abstract concept. All of these factors may impact on an individual’s 
motivation to learn and therefore should be taken into consideration in order to 
maximise learning. 
 
A recent study indicates that people with schizophrenia do respond to these instructional 
factors, as they have been shown to have greater intrinsic motivation when performing a 
cognitive task than those not exposed to the above instructional techniques (Choi et al., 
2009). Participants in this study were given a cognitive task which was contextualised 
into something meaningful, personalised to the individual, and choices were provided 
during the task. The results indicated that adults with schizophrenia acquired more 
cognitive skill, had more motivation for the task, reported feeling more self-competent, 
and had improved attention post treatment in comparison to a control group who were 
not exposed to these instructional techniques. This finding suggests that adults with 
schizophrenia do respond to the same instructional techniques as people without 
schizophrenia. 
 
Further evidence in support of the use of instructional techniques to enhance motivation 
comes from the Neuropsychological Educational Approach to Remediation (NEAR) 
programme, which utilises these methods and has been found to be effective at 
improving cognition in schizophrenia (Medalia et al., 2009). The NEAR programme 
was found to be effective across both inpatient and outpatient facilities for schizophrenic 
patients, and demonstrated sustained significant improvement in executive functioning, 
sustained attention, memory and social and occupational outcome at four month follow 
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up (Hodge et al., 2008). However, this study was in Australia and involved only 40 
patients, revealing an average mild to moderate effect size. 
 
The final factor of the Reciprocal Interactions model, cognitive ability, used to be 
viewed as the primary predictor of learning outcomes until the role of motivation and 
instructional techniques was also recognised (Schunk, 2004). Ability level refers to the 
pre-treatment intellectual ability of the individual which may predict their learning. If a 
severely impaired individual becomes frustrated that they are unable to learn a new task 
this may reduce their motivation to persevere.  The extent of their impairment is also 
important as research indicates those with specific deficits are more able to generalise 
their learning, in comparison to those with global deficits who have greater difficulty 
generalising learning (Fiszdon et al., 2006).  Longtitudinal research aimed at identifying 
the cognitive skills necessary to predict ability to benefit from computerised cognitive 
remediation, found that working memory, verbal learning and sustained auditory 
attention were essential in order to benefit (Kurtz et al., 2008). This would appear to 
reinforce the importance of considering baseline cognitive ability when deciding what 
the most appropriate intervention is.   
 
1.6.2 Influence of Cognitive Impairment in Schizophrenia on Treatment 
Response 
 
Cognitive impairment has been identified as a core symptom of schizophrenia which is 
present from first episode, and most pronounced in the areas of attention, executive 
functioning and verbal memory (Medalia & Choi, 2009). It has also been stated that 
cognitive impairment is not due to treatments such as anti-psychotic medication or a 
result of the symptoms of schizophrenia, but is a specific feature of the illness (Green, 
2006). Heinrichs and Zakzanis (1998) conducted a meta-analysis of studies in the area of 
cognitive impairment in schizophrenia. In their review of 204 studies they concluded 
that all areas of cognition were affected in schizophrenia, and while attention and 
memory appeared to be most impaired, perception and semantic knowledge were least 
affected. In comparison to the general population 70-80% of schizophrenic patients 
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show cognitive deficits, and this increases to 100% when compared to the 
schizophrenic’s own premorbid ability (Heinrichs & Zakzanis, 1998). 
 
Gold (2004) concluded that there was little doubt of the presence of cognitive 
impairment in schizophrenia, and that it was pervasive in all aspects of cognitive 
functioning. It has also been shown to be significantly related to performance in work, 
interpersonal relationships and independent living (McGurk et al., 2007). Furthermore, 
because of the importance of cognitive impairment in schizophrenia it has now been 
identified as an appropriate treatment target as evidenced by two National Institute of 
Mental Health initiatives i.e. Measurement and Treatment Research in Cognition in 
Schizophrenia (MATRICS) and Treatment Units for Research on Neurocognition in 
Schizophrenia (TURNS) (Gold, 2004). 
Gold (2004) comments on the evidence supporting the stability of cognitive impairment 
over time. When comparing first episode schizophrenic patients to those with chronic 
conditions, the results indicate very similar cognitive deficits, both in terms of level and 
range of impairment. This finding has been supported by others such as Hutton et 
al., (2002) who found a stable level of cognitive impairment from first episode through 
to later life. This study involved a group of 28 first episode patients with schizophrenia 
who were compared to a group of 22 patients with chronic schizophrenia. Both groups 
had matched controls and in comparison to the control group both demonstrated 
significant impairments on decision making performance. More recently this finding has 
been replicated in a study looking at both between and within subject stability of 
cognitive impairment in chronic schizophrenia (Pietrzak et al., 2009). In this study 
subjects were tested one month later and no significant difference in test performance 
was found from baseline scores. Furthermore, longitudinal research in this area has 
demonstrated evidence of this stability in the same group of 142 patients with 
schizophrenia over an average period of five years (Heaton et al., 2001). The retest time 
period in this study ranged from six months to ten years and involved subjects both over 
and under 65 years old. The results indicated that factors such as age, gender and length 
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of follow-up period did not impact on the level of cognitive impairment. This study also 
indicated that cognitive performance was stable regardless of changes in medication, 
symptoms or inpatient/outpatient status. These results concur with more recent research 
by Harvey et al., (2005), who also found stable cognitive performance in the same group 
of older adults with schizophrenia who were re-tested after eight weeks.  As such, 
Pietrzak et al., (2009) suggested that their findings corroborate previous research stating 
that cognitive impairment in schizophrenia is stable over time, and is not specific to any 
one cognitive domain. Furthermore, any variation in cognitive performance can be 
viewed as a result of the illness itself rather than mistakes in test administration. 
 
1.6.3. Using Cognitive Deficits To Predict Treatment Response 
A three year study conducted in the United States with 224 prison inmates attempted to 
assess the role of cognitive and emotional deficits in behavioural problems, the 
usefulness of neuropsychological measures in establishing poor responders, and the 
ability of these measures to predict response to treatment (Fishbein et al., 2006). Inmates 
participated in a CBT programme over a nine month period, and a battery of 
neuropsychological assessments were conducted pre and post treatment. Inmates were 
also assessed and categorised in terms of relevant clinical subtypes such as history of 
drug abuse, violence, and psychopathy. Anyone who did not comply with treatment 
remained in the study and was still assessed following the end of the treatment period. 
Non compliance was therefore viewed as a poor response to treatment. Following 
completion of the CBT programme performance outcome was measured and incidents of 
misconduct during treatment noted. The results indicated that neuropsychological 
deficits predicted treatment response i.e. reaction to treatment; gain i.e. benefit received 
from treatment; completion of treatment and institutional behaviour (all aspects of 
treatment performance that were measured in the study), over any other measure such as 
history of drug use or psychopathy. The study concluded that deficits in emotion 
regulation and executive cognitive function are strongly linked to treatment outcome. 
However, this study was based on a prison population recruited from three separate 
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medium/maximum security facilities meaning possible variance between the prisons in 
regards to programme delivery, knowledge of staff and other environmental factors. The 
subjects also did not have any pre-existing mental health difficulties and ranged between 
21-49 years old, as older participants were excluded due to natural cognitive decline and 
the impact of chronic substance misuse on executive functioning. A further exclusion 
factor was an IQ below 70 although there was no rationale given for this. Furthermore, 
the sample was selected from prisoners who had volunteered to participate in the CBT 
programme, indicating that they were therefore already motivated to change. The issue 
of motivation is extremely significant in regards to treatment responsivity and is 
discussed in more detail in section 1.6.4.    
A more recent study in the UK again attempted to use neuropsychological profiles to 
predict functional outcome, however this time with patients suffering from 
schizophrenia (Leeson et al., 2009). The study involved a four year longtitudinal design 
and followed 54 outpatients with schizophrenia in West London, who completed 
assessments when they first presented with psychosis, one year later and a final four year 
follow up. The results indicated that IQ predicted social functioning at four year follow 
up, and that general IQ was a more reliable and sensitive predictor than more specific 
measures of memory and executive functioning. However, this study only involved 54 
patients who were community based and experiencing their first episode of psychosis. 
This is in contrast to mentally disordered offenders who are incarcerated and often 
present with chronic and treatment resistant schizophrenia, as well as co-mordid 
diagnoses such as personality disorder.  
In sum, cognitive deficits do appear to be reliable predictors of response to treatment and 
from the research cited above, this finding is consistent across both patient and non 
patient samples. 
 
1.6.4 Treatment Resistance 
Preston (2000) identified various reasons why people may resist treatment and these will 
now be discussed. Firstly in individuals with mental health difficulties, the nature of the 
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disorder itself may make an individual more likely to resist treatment, as the symptoms 
they experience such as paranoia result in the inability to trust others. Examples of such 
disorders are personality disorders such as anti-social, borderline, paranoid and 
narcissistic which typically present with patient distrust, as well as psychopathy and 
paranoid schizophrenia. Another important variable in treatment resistance is the 
individual’s personality as people who present as hostile, demanding and rebellious are 
more likely to resist treatment. Behavioural variables such as behaving in a violent 
manner or lacking motivation to change may also contribute to resistance. An individual 
may also fear engagement in therapy as they are concerned about confidentiality, or they 
feel hopeless about their ability to change. They may also be achieving secondary gains 
through their behaviour such as increased attention and therefore resist change due to 
self-serving bias. 
 
The type of treatment given may also affect resistance by resulting in a poor match 
between the treatment and client. To illustrate this point, someone with low intellectual 
capability is unlikely to respond well to a talking therapy that does not take into 
consideration their literacy requirements, or level of comprehension. Further treatment 
factors affecting resistance may be the size of the group if participating in group therapy, 
or the length of treatment itself. However, a study comparing preferences for group or 
individual treatment found that matching clients to their preference did not result in 
improved treatment outcome (Renjilian et al., 2001). This finding was the opposite of 
what was hypothesized, however the study involved 75 obese adults participating in a 
weight loss programme and is therefore a very different population from MDO’s.  
 
The environment in which treatment is conducted can affect resistance and this is 
particularly relevant in a maximum secure psychiatric hospital where clients may feel 
they have no choice but to engage in treatment (Preston, 2000).  This will be discussed 
further in section 1.6.4. Finally the importance of the therapeutic alliance has been 
highlighted as the main determinant of treatment resistance and therapeutic outcome. As 
such, the therapeutic alliance is the strongest predictor of treatment outcome and 
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accounts for the majority of variance in treatment outcome (Horvath & Symonds, 1991). 
This is of great significance if the people who provide therapy are also the people 
responsible for deciding your future, for example by recommending suitability for 
transfer to reduced security. Psychiatric nurses in a maximum secure psychiatric hospital 
perform a dual role of caring for patients whilst maintaining required security 
procedures which creates a further dilemma for both patients and staff. Psychiatric 
nurses are responsible for security aspects such as checking patients’ rooms, conducting 
body searches and monitoring phone calls. These security regulations may be strongly 
disliked by patients’ and therefore result in difficulties forming therapeutic relationships 
between nurses and patients (Burrow, 1998). It is also proposed that the balance between 
treatment and security is weighted in favour of security, and their may be professional 
disagreement regarding the aim being violence risk reduction or improving mental 
health (Blackburn, 2000). However, if security is viewed in terms of patient care then it 
is proposed that therapy and security can be combined effectively.   
 
Andrews and Bonta (1994) have identified several important factors in treating offenders 
such as the relationship and contingency principles. The relationship principle states that 
a positive therapeutic relationship can facilitate learning, and the contingency principle 
states that clear boundaries and guidelines must be set between the patient and therapist. 
The therapist must also reinforce positive behaviour while disapproving of negative 
behaviour. This leads on to a further issue faced by staff working with MDO’s which is 
their right to maintain their personal safety while delivering the best possible care to 
their patients (Needham, 2006). When engaging with patients, staff members are 
interpreting cues in terms of what it says about the patients’ illness and their own 
personal safety i.e. the likelihood of being attacked (Whittingdon & Balsamo, 1998). 
This may therefore be considered another complication in establishing a therapeutic 
alliance as staff members are constantly alert to the threat of potential violence.  
 
Within the hospital in this study, psychiatric nurses, psychiatrists and psychologists are 
trained in the delivery of psychological therapies resulting in a multi-disciplinary 
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approach to the delivery of psychological therapy. However, the issue of involving 
forensic psychiatric nurses in psychotherapeutic work itself is problematic for various 
reasons such as shift patterns and staffing constraints, making their attendance and 
participation in group therapy, for example, difficult (Bowers et al., 2000).  Another 
factor is that basic nurse training does not teach therapeutic skills in any depth meaning 
nurses have to be dedicated and willing to pursue further training (Bowers et al., 2000). 
There may also be conflict and competitiveness between professional disciplines 
resulting in nurses’ access to psychotherapy being hampered. For these reasons even 
nurses who may be interested in psychological approaches are deterred from becoming 
more involved, reinforcing a lack of understanding of patients’ therapeutic needs. Given 
that nursing staff spend the most time with patients, this is an important consideration 
when attempting to enhance treatment responsivity.  
    
Given that resistance is common in all therapeutic work it is inevitable in forensic 
populations due to the many variables discussed previously (Preston, 2000). MDO’s 
typically present with co-morbid diagnoses such as schizophrenia and anti-social 
personality disorder, combined with a history of aggressive, violent behaviour and 
substance misuse problems. This makes motivation and engagement in therapy 
particularly problematic for an individual with numerous difficulties. 
 
1.6.5 Factors Impacting The Therapeutic Alliance In A Maximum Secure 
Setting 
The previous section reviewed several variables impacting on resistance to treatment 
such as the therapeutic alliance and environmental factors. In relation to environmental 
factors, Savicki and Cooley (1987) state that mental health nurses are at greater risk of 
developing burnout if they work with patients with complex and long-term mental 
illness, such as schizophrenia. They point out that these patients can be viewed as 
difficult to treat and resistant to change increasing the likelihood of staff burnout. 
Therefore, the staff who work in a maximum secure forensic setting such as the hospital 
in this study are at greater risk of burnout, as the majority of patients in their care are 
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complex and have long term mental health needs. A further consideration is the impact 
burnout can have on the therapeutic milieu. Research by Melchior et al., (1997) has 
shown that staff can display less empathic behaviour, become cold, cynical, have 
negative views of the patients and avoid them. 
 
Nurses have been found to both perpetuate stigma towards mental health and be 
recipients of such stigma (Ross & Goldner, 2009). This study reviewed the research in 
this area and found that nurses who chose to work in psychiatry had negative attitudes, 
and discriminated against people with bipolar personality disorder specifically. 
Psychiatric nurses were also found to be more pessimistic about the outcome of 
psychiatric illnesses than general nurses or the public. However, they also found stigma 
and discrimination within nursing, against colleagues with mental illness and colleagues 
who worked as psychiatric/mental health nurses. This may be an important factor if 
family and/or friends of staff members working in a maximum secure setting, face 
discrimination from their loved ones because of their job.  
 
Forensic psychiatric nurses work with patients who may create feelings of fear, 
repulsion and disgust (Holmes et al., 2006). This may be due to the crimes they have 
committed as a burglar is less likely to cause as much anxiety or disgust as a paedophile 
who tortures and then kills his victims (Holmes et al., 2006).  Forensic nurses therefore 
have to deal with the feelings created not only by the individual’s crimes but also by 
their mental health problems (Jacob et al., 2009). Acknowledging these feelings is vital 
if staff wish to understand the potential impact of them on the therapeutic alliance (Jacob 
et al., 2009).  
 
It has been noted that the use of pejorative language towards mentally disordered 
offenders by nurses in forensic psychiatry is common. This may occur by labelling 
patients with terms such as dangerous, manipulative, monsters, and liars in an attempt to 
dehumanise and depersonalise them (Holmes & Federman, 2003). Using such language 
can be powerful in establishing the mentally ill offender as ‘other’ and therefore 
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impacting on the therapeutic alliance (Holmes & Federman, 2003).  It can also result in 
staff distancing themselves from patients and moving from therapeutic to more custodial 
practices.   
 
A study by Ganong et al., (1987) demonstrated a higher probability of negative 
judgements of patients viewed as uncooperative and complaining, and who have chronic 
illnesses which make nursing staff feel ineffective. MDO’s, particularly those with 
personality disorder match many of these criteria, meaning staff members are more 
likely to become alienated from them. More recent research by Schulze (2007) found 
that from ten studies reviewed of mental health workers attitudes, three quarters found 
similar or more negative attitudes towards the mentally ill than the general public. As a 
result it has been argued that mental health professionals have a significant role in 
contributing to the stigma surrounding mental health (Sartorius, 2002). This study goes 
on to state that stigma and discrimination are the biggest barriers to recovery by those 
suffering from mental illness. Read and Harre (2001) state that negative attitudes are 
more frequently displayed towards those who are most unwell. If this is the case this 
could have significant implications for staff working in forensic settings with extremely 
complex patients. Happell (2005) amongst others has stated that if mental health staff 
display negative attitudes it is likely to impact on patient care. 
 
To summarise, the above information indicates that the attitudes of staff working in 
forensic settings towards patients is extremely important in terms of establishing a 
positive therapeutic milieu, and a strong therapeutic alliance. The research cited 
previously argues that the therapeutic alliance is key to determining if an individual will 
engage in treatment or resist, and it follows that this alliance will be significantly 
affected by the attitude of the therapist towards the patient.  
 
1.6.6 Insight in Psychosis 
 
Insight in regards to psychosis can be viewed as a lack of understanding or awareness of 
psychotic symptoms such as paranoia and delusions. Lack of insight is a common 
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feature of schizophrenia and has been linked to treatment compliance (Kamali et al., 
2001). The importance of lack of insight in mentally disordered offenders is highlighted 
by its’ inclusion as a risk factor in the HCR-20 violence risk assessment (Douglas, 
2008). A recent study addressed the issue of insight into not only clinical symptoms of 
schizophrenia but also neuro-cognitive symptoms (Medalia & Thysen, 2010). As stated 
previously individuals with a diagnosis of schizophrenia will also have significant 
cognitive deficits in attention, executive functioning and memory. This study examined 
71 patients with schizophrenia (15 inpatient and 60 outpatient) who were asked to 
complete measures to assess their clinical and neuro-cognitive symptoms. Clinicians 
were also asked to rate patients’ level of insight into their cognitive abilities. The results 
indicated that 70% of patients had insight into their clinical symptoms in comparison to 
only 27% who had insight into their cognitive abilities. A possible explanation for the 
large difference between insight into clinical and cognitive symptoms may be that 
estimating cognitive ability is simply a difficult task even for healthy individuals. This 
was evidenced by Dunning et al., (2004) who found insight into cognitive ability was 
often inaccurate in healthy adults.   
 
When considering the limitations of this study as stated previously the majority of the 
sample (79%) were outpatients and also 73% of the sample was male. Given that the 
overall sample was relatively small at 71 this makes it difficult to extrapolate findings to 
all patients with schizophrenia, particularly females and inpatients. There is also no 
information supplied on the presence of comorbid diagnoses which may have influenced 
the findings, and the study was conducted in America meaning that due to cultural 
differences results can not necessarily be applied to other parts of the world. 
 
The findings from this study are important when considering the likelihood of patients 
adhering to treatments aimed at improving their cognitive abilities. If a patient does not 
perceive that they have cognitive deficits then they may be less willing to engage in 
interventions such as cognitive remediation. As discussed previously psycho-education 
has been shown to improve clinical symptoms of psychosis. Medalia & Thysen (2010) 
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note that all patients in their study were engaged in treatment that delivered psycho-
education about psychosis but not cognitive deficits. As such they state that it may be 
beneficial to incorporate information on cognitive symptoms of psychosis in psycho-
educational programmes. This is based on findings from a study which used a psycho-
educational programme called ‘Braincheck’ to teach patients with schizophrenia about 
cognitive deficits in mental illness. The results revealed that patients with schizophrenia 
who participated in the programme had greater awareness of cognitive deficits in 
comparison to the control group. It would therefore appear that it is possible to improve 
insight into cognitive deficits.  
 
Related to this is the concept of metacognitive training which has been developed to 
improve psychotic symptoms. Metacognitive refers to the ability to consider how your 
mind operates, and means that we are aware when we may have a false memory or when 
we jump to conclusions. The training aims to teach patients about cognitive biases and 
errors in problem solving as this may be involved in the development of delusional 
belief systems. People with psychosis are often unaware they have cognitive biases and 
are more prone to them (Moritz & Woodward, 2007). In support of metacognitive 
training a small pilot study was conducted which showed reduced severity and improved 
awareness of delusions, their illness, and the attribution of delusions to their illness 
combined with reduced depression (Favrod et al., 2010). However, this study involved 
only 18 participants in Switzerland and 11 of the sample participated in two cycles of the 
programme, meaning they received twice the dose of treatment that the remaining 
participants received. It may therefore be argued that participants are more likely to 
improve the more treatment they receive, and hence this may be a possible explanation 
for the findings, rather than the nature of the training itself. Although the authors 
acknowledge the small sample size and the exploratory nature of the study, it is 
proposed that the findings may serve as a blueprint for further research in this area. 
 
Bentall et al., (2001) proposed an integrative model addressing the issue of how 
attributions influence self-representation which then influences future attributions. This 
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is known as the attribution self-representation cycle and it is argued that due to factors 
such as cognitive bias, negative events are attributed to external factors leading to a 
paranoid view of the world. Related to this the issue of social cognition in schizophrenia 
has been highlighted as a treatment target (Green et al., 2008). This is evidenced by its’ 
inclusion in the MATRICS Consensus Cognitive Battery for clinical trials in 
schizophrenia as one of seven domains. As stated previously, understanding social 
cognition in schizophrenia may help explain the development of clinical symptoms such 
as delusions and paranoia, hence the need for further research in this area.  
 
Over the past 20 years neurodevelopmental models of schizophrenia have been proposed 
to explain the aetiology of this illness. There is variation amongst these models but the 
main focus has been on injury to the brain during early development (Rapoport, 2005). It 
has been proposed that in any neurodevelopmental model of schizophrenia 80% of the 
model can be explained by genetic factors, meaning the rest must be accounted for by 
environmental factors affecting brain development. However, there is a lack of 
specificity regarding the timing of onset of the illness and studies in early onset patients 
are minimal. As such further research is necessary in order to ascertain if these findings 
are consistent across differing populations and a larger sample. Animal models of 
schizophrenia have also been explored using rats and monkeys to aid understanding of 
the processes involved in the illness. A study using rats with an insult to the 
hippocampus during maturation, resulted in abnormal dopamine related behaviours and 
deficits in working memory and social impairments, similar to the negative symptoms of 
schizophrenia (Lipska et al., 2004). This is in comparison to previous animal models 
that used permanent lesions to the hippocampus in rats, whereas the method involved in 
this study was temporary and reversible.  
 1.6.7 Motivation 
Motivation can be viewed as an important internal treatment responsivity factor, and this 
has been described as the probability that a person will enter into, continue, and adhere 
to a particular plan (Miller & Rollnick, 1991). They argue that motivation is a dynamic 
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concept and as such can be influenced by external factors such as input from a therapist. 
This point is significant as it highlights the importance of environmental factors which 
influence treatment response, and recognizes that motivation is not soley dependent on 
internal characteristics. Kennedy (2000) states that the majority of offenders lack 
motivation and are resistant to treatment, often unwilling to accept they have a problem. 
They therefore require pre-treatment motivational interviewing (MI) to address these 
issues prior to any formal treatment. MI is a psychosocial intervention which addresses 
many of the barriers to adherence by using an empathic approach to help people 
establish the costs and benefits of their behaviour (Corrigan, 2002). The approach was 
originally developed for substance misuse patients (Miller & Rollnick, 1991) but has 
since been applied to other mental health populations. There is also evidence that this 
technique can be successfully used with psychotic patients, by making appropriate 
adjustments such as breaking the task down into small concrete steps. Bellack and 
DiClemente (1999) state that by doing so people with cognitive deficits can still 
understand and benefit from MI. Other research states that cost benefit analysis involved 
in MI can lead to significant improvement in psychotic symptoms such as delusions and 
hallucinations (Drury et al., 1996).  
 
The Transtheoretical Model or Stages of Change model (Prochaska & DiClemente, 
1986) attempts to assess an individual’s readiness or motivation for change, and by 
doing so, any intervention can subsequently be tailored to match this stage. Research 
using this model has been conducted on the process of change in psychotherapy in the 
field of substance abuse, criminality and high risk health behaviours. The basic premise 
is that individuals vary in their readiness for change and therefore different therapeutic 
approaches should be used depending on their stage of change. The five stages which 
have been identified are precontemplation, contemplation, preparation/determination, 
action and maintenance. The first stage called precontemplation is where the individual 
does not accept they have a problem and therefore is not considering change. In the next 
stage of contemplation the individual is ambivalent about change, and although 
accepting there is a problem may not be able to change or be unwilling to do so. The 
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preparation/determination stage is where the individual may have commenced making 
some small changes in behaviour. The action stage is where the individual has 
committed to change, and as a result will typically engage in some form of therapy. The 
final stage called maintenance is where the individual attempts to maintain any changes 
made, and prevent any potential future relapse. As a result this model highlights the 
importance of addressing treatment motivation or readiness, and the role it plays in 
enhancing treatment responsivity. 
Motivation can be viewed in two ways by comparing intrinsic versus extrinsic 
motivation. Intrinsic motivation describes an individual’s desire to participate in an 
activity which they view as interesting and relevant. In comparison extrinsic motivation 
can occur when a concrete outcome is achieved such as money or a reward (Medalia & 
Choi, 2009). Numerous studies have demonstrated that intrinsic motivation is linked to 
better engagement in surroundings, improved self-esteem and sense of well-being, better 
learning and creativity and greater persistence in performance (Deci & Ryan, 2008; 
Vansteenkiste et al., 2004). Extrinsic motivators can reduce the level of learning that 
occurs and it is recommended they are used with caution (Elliot & Dweck, 2005).  
A study involving community-based participants attending a cognitive remediation 
programme, separated them into high and low intrinsic motivation based on frequent, 
voluntary attendance. Those with high intrinsic motivation produced a large effect size 
when measured on processing speed as an outcome measure. This was in comparison to 
the low intrinsically motivated participants who produced a very small effect size on the 
outcome measure (Choi & Medalia, 2005). However, this study involved a psychiatric 
sample with mixed diagnoses and consisted of only 48 patients, therefore is it 
questionable how possible it is to extrapolate these findings.   
A more recent study by Nakagami et al., (2008) investigated the relationship between 
intrinsic motivation, psychosocial functioning and neurocognition in 120 patients with 
schizophrenia participating in outpatient psychosocial rehabilitation. This study 
highlighted the presence of impairments in neurocognition, motivation and psychosocial 
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functioning in schizophrenia, and aimed to assess how these factors are related. The 
results indicated a strong mediating role of intrinsic motivation in the relationship 
between psychosocial functioning and neurocognition. This suggests that intrinsic 
motivation is crucial in determining the relationship between functional change and 
neurocognition in schizophrenia.  They also found that neurocognition had no effect on 
the relationship between psychosocial functioning and intrinsic motivation. These results 
indicate that the relationship between psychosocial functioning and neurocognition in 
schizophrenia can be explained by intrinsic motivation. As such the authors conclude 
that intrinsic motivation should be considered a viable treatment target, and treatment 
should be geared towards enhancing intrinsic motivation in order to maximize functional 
outcomes. 
If one accepts the importance of intrinsic motivation in learning, it is then necessary to 
consider the factors that influence motivation. Schizophrenia itself as a disorder involves 
reduced motivation, a symptom known as avolition which is targeted by treatment such 
as medication (Medalia & Choi, 2009). Factors which have been identified as affecting 
intrinsic motivation are interpersonal relationships, instructional techniques and learning 
environment. The importance of interpersonal relationships is demonstrated through the 
teacher/student relationship which has been shown to influence learning (Schunk & 
Pajares, 2005). A controlling environment where incentives are used and people feel 
pressured to meet deadlines, combined with an authoritarian approach reduces 
motivation, self-determination and sense of autonomy (Ryan & Deci, 2000). Other 
research has also found reduced learning and persistence in learning, along with higher 
passivity in a controlling environment. In comparison, an environment which avoids 
controlling language, reduces the use of incentives and promotes the learner’s 
individuality, is more likely to result in improved test performance, intrinsic motivation, 
learning and sense of well-being (Vansteenkiste et al., 2004). 
Recent research indicates that an environment which supports autonomy enhances 
intrinsic motivation meaning that schizophrenic patients have some control over their 
learning, the value of it is evident to them and they have the opportunity to demonstrate 
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their competency (Choi & Medalia, 2009). These are important factors to consider when 
treating mentally disordered offenders who are incarcerated against their will. 
 
It has been proposed that low engagement in offender treatment programmes is common 
(McMurran, 2002). In considering treatment with offenders it is argued that motivation 
relates to goal-seeking factors, and responsivity is a trait of treatment programmes as 
opposed to the individual. For this reason the term readiness is suggested as being more 
inclusive as it considers both individual characteristics and environmental situations 
which may facilitate therapeutic change (Howells & Day, 2007). This is the basis behind 
the Multifactor Offender Readiness Model (Ward et al., 2004) which proposes that 
readiness is an interaction between individual and external factors. The model states that 
the individual’s environment may influence their mood and beliefs, for example being 
placed in a maximum secure setting may make an individual feel depressed and believe 
that they are dangerous. It also recognises that engagement is necessary but not 
sufficient for effective clinical change during treatment. Internal factors can be split into 
cognitive, affective, volitional, behavioural and identity factors. Cognitive factors that 
may occur are if for example the individual may have previous negative experiences of 
treatment, and therefore have negative expectations of their ability to benefit from 
treatment (Howells & Day, 2007). Beliefs regarding self-efficacy e.g. I can get better, 
and the costs versus benefits of treatment are also important factors. 
 
In relation to affective factors it is suggested that readiness is influenced by the capacity 
to access and experience emotions, the ability to express emotions and the ability to 
reflect on them. An inability to do so is likely to impede treatment programmes where 
exploration of emotions and their impact on offending behaviour is required (Howells, 
Day & Wright, 2004). It also seems likely that very high or low emotional states will 
reduce readiness for treatment, for example a person with severe depression is less likely 
to be ready to engage in treatment that someone with moderate depression (Howells & 
Day, 2007).   
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Behavioural factors that may influence readiness for treatment are the ability to seek 
help when required, to develop relationships with others and navigate basic social 
situations such as discussion of thoughts and feelings. Volitional or motivational factors 
are understood in terms of goals i.e. if the goals of the offender match those of the 
treatment programme then they will be ready to engage in treatment. Finally identity 
factors are important in readiness for treatment as their identity must be amenable to 
change as necessitated by the programme of treatment (Ward et al., 2004). This means 
the person’s values and beliefs must change from perceiving themselves for example as 
a criminal to a person with a mental health difficulty. 
 
1.7 Measuring Treatment Gain 
The issue of how to measure treatment gain has been discussed by Jacobson and Truax 
(1991), who state that the effects of treatment are typically measured by comparison of 
means using statistical tests. However, they note that using statistical tests is limited as 
they do not reveal any information on the variability of response within treatment which 
is very important for clinicians to know. Even if a statistically significant effect is found 
this not does tell the clinician anything of the clinical significance of the finding. 
Clinicians wish to know about the efficacy of psychotherapy and the impact on patients, 
if they have received benefit from it or if it has made a difference to their lives. These 
are questions which statistical comparisons can not answer in any great depth, 
particularly on an individual basis.   
The effect size statistic which is used in meta-analysis and measures the size of the 
treatment effect is more informative than standard statistical tests, yet is subject to the 
same criticisms discussed previously in regard to standard statistical tests. The clinical 
significance of an effect can be viewed as meeting the standards set by clinicians, 
researchers and the patient themselves (Jacobson & Truax, 1991). However, there is no 
consensus regarding what these standards should be and several suggestions have been 
made. Wolf (1978) proposes that there should be a level of change that it recognisable 
by significant others, whilst Kazdin and Wilson (1978) state there should be an 
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elimination of the presenting problem. Other suggestions are that there should be 
normative or high end-state functioning by the end of therapy, or changes that 
significantly reduce the risk for many health problems (Nietzel & Trull, 1988; 
Mavissakalian, 1986).     
Jacobson and Truax (1991) proposed their reliable change index as a method of 
determining clinically significant change, which compares functional and dysfunctional 
distributions. However, using this approach appeared to result in weaker significance 
levels when data that had been significant using statistical techniques were reanalysed. 
This has also been found in other research using similar methods for determining clinical 
significance rather than statistical tests (Robinson et al., 1990). It has also been noted 
that attempting to operationalise clinical significance in terms of a return to normal 
functioning may not be appropriate in disorders such as schizophrenia. Recovering to 
pre-morbid functioning is something that is arguably unachievable in such disorders, and 
a standard that most would not expect from treatment. A further issue in determining 
clinical significance is the use of reliable and valid psychometrics which yield norms for 
functional and dysfunctional distributions. Without normative data standardised cut off 
points can not be established and used in establishing clinical significance. Jacobson and 
Truax (1991) conclude that the optimal method for determining clinical significance is 
yet to be agreed.     
Regarding what should be measured in treatment, factors such as knowledge of 
programme content, patient confidence, individual and group disclosure, insight, 
attendance, participation, generalisation of skills to real life, skills acquisition, and 
performance and therapeutic alliance are all important for staff to measure (Kennedy, 
1999). However, the relevance of responsivity factors on treatment of offenders can only 
truly be measured by analysis of recidivism rates. If offenders who demonstrate good 
treatment responsivity have reduced recidivism rates, then their treatment responsivity 
has extended beyond the actual period of treatment.   
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1.8 The Relevance Of Assessing Cognitive Impairment And Treatment 
Responsivity   
Intellectual functioning can be regarded as an important consideration when assessing 
treatment responsivity. Fabiano, Porporino, and Robinson (1991) highlight that 
cognitive skills programmes are more effective with offenders of average to high-
average intelligence, than those with below average intelligence. This being the case it 
therefore seems extremely pertinent to be aware of an individual’s cognitive abilities 
when determining the most appropriate treatment option. Furthermore, if we accept that 
cognitive impairment impacts on a person’s response to treatment, which has a 
subsequent impact on recidivism, it is crucial that we address both their cognitive 
impairment and their treatment responsivity. Managing the risk of reoffending in 
mentally disordered offenders is an integral part of the rehabilitation process, and is 
achieved through factors such as treatment, monitoring and supervision. Therefore, an 
individual’s response to treatment is crucially important in order to reduce the 
probability of reoffending, and successfully rehabilitate offenders (Kennedy, 2000). 
1.8.1 Treatment Responsivity and Risk Management 
By matching offenders to the most appropriate treatment, therapists to offenders and 
group treatments to therapists skilled in their delivery, the effectiveness of treatment 
may be enhanced. These principles of treatment responsivity should be an integral part 
of a comprehensive risk assessment and management plan. It is argued that failure to 
include assessment of treatment responsivity, may result in wasting resources and 
undermining any potential treatment gains as well as potentially reducing public safety 
(Kennedy, 2000). If responsivity is successfully assessed this will allow more effective 
treatments to be developed for offenders.  
 
The relevance of cognitive impairment in risk assessment is highlighted by the fact that 
it is being considered for inclusion in the revised edition of the HCR-20, which is 
commonly considered as the benchmark in violence risk assessment (Douglas, 2008). 
Treatability as a risk item has also been included in the Short Term Assessment of Risk 
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and Treatability (START, Webster et al; 2006) indicating growing awareness of the 
importance of assessing factors such as treatment readiness, responsivity and gain. 
Furthermore, if we accept that cognitive impairment is a dynamic risk variable this 
means that it should be amenable to change as stated by Fishbein et al., (2006). This 
would concur with the fact that it has been identified as a treatment target by two 
National Institute for Mental Health initiatives as stated previously.  
 
1.8.2 Cognitive Remediation 
The importance of cognitive impairment in schizophrenia is highlighted by the fact that 
it can predict if a person will be able to meet their treatment goals. This has consistently 
been demonstrated through the link between cognitive impairment and poor problem 
solving skills and inability to benefit from rehabilitation services in schizophrenia 
(Green et al., 2004).  Treatment options include groups such as psychosocial training 
which aim to teach people life skills such as social interaction, problem solving and 
relapse prevention. However, a person with severe attention difficulties or memory 
problems may be unable to benefit from this, as they are unable to attend to the 
information and/or can not remember it. Poor working memory may also mean difficulty 
following conversations and remembering questions just asked, and impaired processing 
speed may mean others in a group setting respond faster resulting in the individual being 
perceived as not fully engaging. Due to the increasing awareness of such problems 
behavioural programmes are being developed in an attempt to address these deficits. 
These programmes are based on the research evidence which indicates that people with 
schizophrenia can learn new skills and that cognitive deficits can therefore be changed 
(Medalia & Choi, 2009). There are various names for such programmes ranging from 
cognitive remediation to rehabilitation to training. However, as it is unlikely that full 
premorbid ability will be restored it has been suggested that the most appropriate term 
may be cognitive training (Tomas et al., 2010). It may be helpful to view cognitive 
remediation as a method of teaching people how to pay attention, problem solve, 
improve memory and information processing speed (Medalia & Choi, 2009). It is an 
evidence based strategy consisting of compensatory interventions or cognitive drills 
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aimed at improving neuropsychological functioning. By improving executive 
functioning, memory and attention the individual should also have improved 
psychosocial functioning, and be better equipped to deal with daily living. There are 
several methods of cognitive remediation ranging from group to individual programmes, 
and computerised or paper and pencil programmes. 
 
A recent review in the area of cognitive remediation in schizophrenia, highlights six 
meta-analyses reporting moderate effect sizes on cognitive performance and daily 
functioning following remediation programmes (Medalia & Choi, 2009). These results 
appear to indicate the potential benefits of cognitive remediation, and reinforce the 
possible improvements that can be made not only in cognitive deficits but also daily 
functioning. However, this study did not comment on the impact of cognitive 
remediation on symptoms of schizophrenia, which has been addressed in a meta-analysis 
of 26 randomised controlled trials involving 1151 patients. This study by McGurk et al., 
(2007) analysed the impact of cognitive remediation programmes on cognitive 
performance, psychosocial functioning and symptoms of schizophrenia. The results 
indicated a medium effect size for cognitive performance and slightly smaller effect size 
for psychosocial functioning, and a small effect size for symptoms. The study also noted 
that improvements in psychosocial functioning were greatest when cognitive 
remediation programmes were combined with psychiatric rehabilitation.   
 
1.9 Summary of cognitive impairment and treatment responsivity information 
From the research discussed there appears to be clear evidence of the existence of 
cognitive impairment in schizophrenia (e.g. Gold, 2004). This has significant 
implications for an individual’s response to treatment, along with the many other 
identified factors that can influence treatment responsivity. Given the high incidence of 
schizophrenia amongst MDO’s, it follows that there is a high level of cognitive 
impairment in this population. However, in reviewing the research there appears to be a 
lack of studies regarding the impact of cognitive impairment on treatment gain and 
adherence in mentally disordered offenders. This exploratory study aims to address this 
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gap in the literature. The research rationale for the current study, aims, research 
hypotheses, and research questions have been developed from the findings of the 




























2 THE THESIS RESEARCH HYPOTHESES AND QUESTIONS 
Research to date has examined the relationship between cognitive functioning and 
treatment responsivity in a prison population (Fishbein et al., 2006). However, the 
author is not aware of any studies that have investigated the impact of cognitive 
impairment on response to treatment in mentally disordered offenders. 
 
This study aims to identify relevant neuropsychological profiles that have an impact 
upon an individuals’ response to treatment specifically in mentally disordered offenders. 
By investigating this issue, the importance of establishing levels of cognitive impairment 
and incorporating this into treatment delivery can become a more standard approach in 
the treatment of mentally disordered offenders. The findings from this study would 
appear to be extremely important in considering the relevance of this information for 
risk management. More specifically the relevance and need for cognitive remediation 
programmes may be highlighted as a first step prior to delivering psychological 
interventions. A quantitative research approach was used to investigate the impact of 
cognitive functioning (IQ, memory executive functioning, and attention) on treatment 
gain (measured by difference in pre and post treatment scores on relevant psychometric 
measures).  
 
The research question, from which the research hypotheses were developed, was:  
What impact does cognitive impairment have on response to treatment in mentally 
disordered offenders in maximum secure psychiatric care? Based on this research 
question and in relation to relevant research the following research hypotheses were 
generated:  
 
Hypothesis 1:  
Research hypothesis: There will be a significant positive association between memory 
functioning as measured by the Wechsler Memory Scale Third Edition (WMS-III, 
Wechsler, 1997), and treatment gain as measured by pre and post treatment scores. 
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Null Hypothesis: There will be no relationship between memory functioning as 
measured by the Wechsler Memory Scale Third Edition (WMS-III, Wechsler, 1997), 
and treatment gain as measured by pre and post treatment scores. 
 
Hypothesis 2 
Research hypothesis: There will be a significant positive association between attention 
functioning as measured by the Test of Variables of Attention (TOVA, Greenberg & 
Waldman, 1993), and treatment gain as measured by pre and post treatment scores. 
 
Null Hypothesis: There will be no relationship between attention functioning as 
measured by the Test of Variables of Attention (TOVA, Greenberg & Waldman, 1993), 
and treatment gain as measured by pre and post treatment scores. 
 
Hypothesis 3 
Research hypothesis: There will be a significant positive association between executive 
functioning as measured by the Cambridge Automated Neuropsychological Test 
Automated Battery (CANTAB, Sahakian et al., 1988), and the Speed and Capacity of 
Language Processing Test (SCOLP, Baddeley, Emslie & Nimmo-Smith, 1992), and 
treatment gain as measured by pre and post treatment scores. 
 
Null Hypothesis: There will be no relationship between executive functioning as 
measured by the Cambridge Automated Neuropsychological Test Automated Battery 
(CANTAB, Sahakian et al., 1988), and the Speed and Capacity of Language Processing 
Test (SCOLP, Baddeley, Emslie & Nimmo-Smith, 1992), and treatment gain as 
measured by pre and post treatment scores. 
 
Hypothesis 4 
Research hypothesis: There will be a significant positive association between IQ as 
measured by the Wechsler Adult Intelligence Scale Third Edition (WAIS-III, Wechsler, 
1997), and treatment gain as measured by pre and post treatment scores. 
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Null Hypothesis: There will be no relationship between IQ as measured by the Wechsler 
Adult Intelligence Scale Third Edition (WAIS-III, Wechsler, 1997), and treatment gain 
as measured by pre and post treatment scores. 
 
 
 2.1 Exploratory Questions 
The following exploratory questions were also considered in relation to the research 
findings:  
 
i) Are some forms of cognitive impairment more predictive than others in determining 
response to treatment? 
 
ii) Is there a difference between the type of group treatment and the consequent impact 
on a patient’s response? 
  
iii) Is there a difference between schizophrenia or other diagnoses in regards to cognitive 
impairment and response to treatment? 
 
iv) Does age have an impact on cognitive impairment and response to treatment when 










3 METHODOLOGY  
 3.1 Design 
This exploratory study utilised a cohort quantitative research design to investigate the 
research hypotheses and research questions. The data were obtained via the 
administration of neuropsychological assessments and self-report measures. All 
hypotheses were tested using a correlational design followed by regression analysis. 
This was to determine if there is an association between pre- and post-treatment scores 
and participants’ cognitive scores. The dependent variables were the participants’ 
treatment gain scores (measured by the difference between pre-and post-treatment 
scores). The independent variables were the participants’ memory, IQ, executive 
functioning and attention scores. The other research questions (refer to chapter 2, section 
2.1) were explored through a combination of correlational and between-participants 
designs. The design was dependent on the type of data (e.g. continuous, categorical) that 
was being analysed.  
 
 3.2 Power analysis 
The study involved the analysis of existing data collected from a neuropsychological 
study using a cohort design, where all patients within the hospital in this study were 
asked to participate in a research study. During a one year period all patients resident in, 
or admitted, to the hospital were offered the chance to participate in the study. Newly 
admitted patients were approached whilst on the admissions ward while continuing care 
patients were identified and the order in which they were approached randomised. These 
data have been compared with data collected from the administration of pre- and post-
group psychometrics, as part of routine service evaluation of psychological group 
therapies in the Psychological Therapies Service (PTS) in the hospital. Other relevant 
data on cognitive functioning collected from the WAIS/WMS writer (computer software 
package for scoring the WAIS and WMS cognitive assessments) was included, in order 
to establish the maximum sample size and allow more robust statistical analysis to be 
performed. Therefore, as the study involved a pre defined cohort and no further direct 
patient contact was required for this study a power analysis was not necessary. 
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3.3 Participants 
This study involved the use of existing data meaning that no new participants were 
recruited. The data being used for this study was collected from participants who were 
approached when they were inpatients at the hospital in this study during the period of 
the study. The patients who participated in the neuropsychological study and had also 
completed group psychological therapy were then matched. This resulted in five 
separate groups of various sizes as follows:- 
 
Group 1 - Drug and Alcohol Education Group, N = 83 participants 
Group 2 - Drug and Alcohol Relapse Prevention Group, N = 61 participants 
Group 3 - Social Problem Solving Group, N = 49 participants 
Group 4 - Anger Management Group, N = 44 participants 
Group 5 - Coping with Mental Illness Group, N = 66 participants 
* There are other psychological groups within the PTS service but due to low numbers and lack of data it 
was not possible to include them 
 
The predictor variables for the study were:- executive functioning, attention, memory 
and IQ score. This is based on previous research by Fishbein et al., (2006) who looked at 




As stated previously the neuropsychological data being used for this study was collected 
as part of an original research study, and the following criteria were applied for the 
neuropsychological study:- 
Inclusion Criteria:- 
     Inpatient at the hospital in this study 
     Responsible Medical Officer (RMO) consent confirming the patient was 
capable of giving informed consent 
     Patient consent to participate in study 
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Exclusion Criteria:- 
     Individuals who were unable to give informed consent according to their RMO  
  Individuals who do not consent to participation in study 
 
Individuals who participated in the neuropsychological research study were matched to 
their corresponding psychological therapies service data and results compared 
accordingly. 
 
 3.5 Participant confidentiality 
The completed questionnaires and the consent forms from the neuropsychological study 
were kept in a locked filing cabinet in the Psychology Department of the hospital. The 
service evaluation data collected from the Psychological Therapies Service and the data 
collected from the WAIS/WMS Writer was collated into a database. Once the data 
collation was completed no identifying information was included in the electronic 
database.  
 
 3.6 Ethical issues 
Mentally disordered offenders are a potentially vulnerable group due to the severe and 
enduring nature of conditions such as schizophrenia, and the fact that they are 
incarcerated against their will due to their offending behaviour. Ethical issues, in line 
with British Psychological Society Code of Ethics and Conduct (British Psychological 
Society, 2009) were adhered to throughout the neuropsychological study in order to 
reduce potential burden to the participants. Participants were informed that they had the 
right to withdraw from the research at any stage after giving consent. Furthermore, the 
inclusion and exclusion criteria were designed to ensure that the Responsible Medical 
Officer (RMO) for each patient was initially approached, to decide if they thought the 
patient was capable of giving informed consent to participate in the neuropsychological 
research.  
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If a participant became upset during the study the researcher would refer them to their 
keyworker or RMO. Participants were also aware that they could contact the researcher 
via a member of nursing staff in case they wished to discuss any aspect of the study, 
prior to or following completion of the neuropsychological assessments.  
 
 3.7 Ethical approval  
The South East Scotland Research Ethics Service reviewed the research proposal and 
determined that the study did not require ethical approval under NHS research 
governance arrangements (see Appendix 1). Approval was granted from the University 
of Edinburgh Clinical Psychology Ethics Committee (see Appendix 2) and the State 
Hospital Research Committee (see Appendix 3).  
 
 3.8 Measures 
The participants who took part the neuropsychological research study completed the 
following neuropsychological assessments:-  
 
Wechsler Adult Intelligence Scale Third Edition (WAIS-III, Wechsler, 1997) 
This measure aims to assess the intellectual capacity of adults aged 16-89 (Wechsler, 
1997). The measure contains the traditional three composite IQ scores of Verbal, 
Performance and Full Scale along with four Index Scores; Verbal Comprehension, 
Perceptual Organisation, Working Memory and Processing Speed. There are also scaled 
scores for each subtest that constitutes the Index Scores, such as Vocabulary and 
Arithmetic. 
 
Wechsler Memory Scale - Third Edition (WMS-III, Wechsler, 1997) 
This measure assesses the learning and memory functioning of adults aged 16-89 
(Wechsler, 1997). The scale comprises six subtests looking at Auditory and Visual 
Immediate Memory; Auditory, Visual and Auditory Recognition Delayed Memory and 
finally Working Memory. As with the WAIS the WMS also produces scaled scores for 
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each subtest such as ‘Logical Memory’ and ‘Faces Recognition’. The reliability and 
validity of both the WAIS-III and WMS-III have been found to be very high, and this is 
evidenced by consistent scores across populations such as brain injury and Alzheimer’s 
disease (Wechsler, 1997). 
 
Cambridge Automated Neuropsychological Test Automated Battery (CANTAB) 
(Sahakian et al., 1988) 
This measure assesses neuropsychological functioning by measuring memory and 
learning, attention and executive functioning, and is administered via a computer 
programme. There are numerous subtests in the battery and as such, for the purposes of 
this study, the following subtests were selected as they measured executive functioning 
and attention:- 
 Rapid Visual Information Processing (RVIP) – a test of sustained attention 
 Stockings of Cambridge Task (SOC) – a spatial planning test 
 Big/Little Circle (BLC) – tests comprehension, learning and reversal of a rule 
 Intra-Extra Dimensional Set Shift Test (IED) - assesses visual discrimination 
and attentional set formation as well as maintenance, shifting and flexibility 
of attention. 
The test-retest reliability of the CANTAB is satisfactory with some subtests having 
correlations of over 0.9. It has been shown to be a valid measure in numerous patient 
populations and is used in at least 50 different countries (Cambridge Cognition, 2011).  
Speed and Capacity of Language Processing Test (SCOLP) (Baddeley, Emslie & 
Nimmo-Smith, 1992) 
This measure assesses the speed of information processing to allow identification of 
cognitive slowing in brain damaged patients, and is therefore a measure of executive 
functioning. It consists of two measures, the Spot the Word Test (SWT) and the Speed 
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of Comprehension Test (SCT). Reliability has been calculated as 0.88 on a sample of 
224, and validity has been established as good and the test is quickly and easily 
administered (http://www.psychcorp.co.uk).  
 
Test of Variables of Attention Continuous Performance Test (TOVA) (Greenberg & 
Waldman, 1993) 
This test is a version of a continuous performance task and measures sustained and 
selective attention via a computer “game”. The tests produces scores on response time, 
response time variability, commission (impulsivity/disinhibition) errors and omission 
(inattention) errors. Administration takes 21.6 minutes and involves measuring 
responses to either auditory or visual stimuli.  It is both reliable and valid and is used as 
part of the assessment process for attention deficit disorders. The sensitivity and 
specificity of the measure have been reported as 0.80 for both (T.O.V.A Clinical 
manual, 2007).  
 
 3.9 Psychological Therapies Service Measures 
As there is a significant amount of data generated from each of the psychological 
therapy groups assessed in this study, in order to minimise the number of variables, an 
exploratory analysis was conducted to determine the optimum measure for each of the 
groups should more than one be available. On the basis of this the following measures 
were selected as they demonstrated significant change both in this study and in previous 
research within the hospital. These measures were administered pre and post treatment 
for each of the groups, and information on the measures as well as background 
information on the groups is now described. In order to facilitate reading and 
understanding of the results they will be presented in individual chapters following a 
description of each of the groups. Prior to this however, a brief over view of the data set 
and how statistical analyses were conducted will be described in chapter 4. 
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4 RESULTS  
4.1 Overview 
The data were analysed using the Statistical Package for Social Sciences (SPSS)/ 
Predictive Analytics SoftWare (PASW) Version 18.0 for Windows. The stages of 
analyses were as follows: 
i) Characteristics of each group were explored using univariate and bivariate 
statistical tests.  
ii) Relationships between treatment outcome scores were explored with 
cognitive-related variables.  
iii) The contribution of relevant predictor variables on participants’ treatment 
outcome scores were explored.  
 
The strategy of analyses and the results for each stage is provided below.  
 
4.2 Strategy of analysis   
Statistical tests were selected based on the type of data being analysed. Tests of 
normality of distribution and homogeneity of variance were used to evaluate the data 
against assumptions for parametric tests (Dancey & Reidy, 2004). The Shapiro-Wilk test 
was used to determine if the distribution of scores differed significantly from normality 
as the group sizes were under fifty in all but two of the groups. The Kolmogorov-
Smirnov test was used for the two groups that were larger than fifty. When the data did 
not adhere to the assumptions of parametric tests, transformation was used to make the 
data normally distributed. As the data consisted of zero and minus values in order to 
perform the transformation the zero and minus values had to be removed. An arbitrary 
value of 100 was therefore added to all the data points and this therefore allowed 
transformation of the data to occur. If the data were still not normally distributed 




4.3 Results: The sample characteristics  
The data were collected from a total of 114 participants all of whom were male. Some 
participants engaged in more than one group treatment resulting in the group sizes 
outlined in section 3.3. However, although this data should have been available not all 
data sets were complete meaning that the group sizes were reduced in the final analysis. 
Information on diagnoses was also not available for all participants as some had not 
been formally diagnosed at the time of assessment, and ethical approval had not been 
obtained to access patient files for this information. Demographic and clinical variables 
for the participants are summarised in the following tables:- 
 
Table 4.1 Summary of participant demographic and clinical variables 
 
 Mean Standard Deviation Range 
Age (years) 37.91 10.37 20-67 years 
 
 
Table 4.2 Summary of Diagnosis Information for participants 
 













Correlational analyses were conducted to assess which cognitive predictor variables 
were significantly related to age. This series of analysis was in relation to the research 
question does age have an impact on cognitive impairment and response to treatment 
when considered as a predictive factor? No significant relationships were found and 
therefore a regression analysis was not conducted. 
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4.4 Strategy of analysis: The Preliminary analysis  
To investigate the relationship between treatment gain scores and cognitive results, 
univariate and bivariate statistical tests were carried out.  
 
4.5 Primary analysis: Strategy of analysis  
To identify variables that significantly influence participants’ treatment gain scores 
multiple regression analyses were conducted. This statistical test was chosen as the 
dependent variable (participants’ treatment gain scores) was a continuous variable. 
Multiple regression is a common method for modelling relationships between a DV and 
multiple IVs.  
 
Separate regression models were run for each of the dependent variables (DVs) in each 
of the groups described in section 3.3. Predictor variables (PVs) were included if they 
were significantly associated with the DV as demonstrated in the preliminary analyses. 
When more than one PV was significantly related to the DV the analysis was run with 
the inclusion of all relevant predictor variables. The simultaneous or ‘enter’ method in 
SPSS was used for the regression analysis where the author specified the predictor 
variables in each model. This was due to the relatively low numbers involved in each 
group, as statistical procedures such as stepwise regression should be used with caution 
and when there is a large sample size (Brace et al., 2006). As a result, where possible 
dependent on factors such as collinearity, variables were grouped together in models 
based on if they measured the same cognitive domain e.g. attention. 
 
There are several statistical assumptions associated with multiple regression analyses 
(Dancey & Reidy, 2004). These will now be discussed along with information outlining 






Assumption 1: Sufficient participants are required 
How assessed: The groups varied in size and therefore the number of predictor variables 
entered into the regression model was dependent on this. However, as a general rule 15 
participants were required per predictor variable and this was adhered to throughout the 
analysis. This was based on the following information:- there are several methods for 
determining the number of participants required in a regression analysis, and Cohen 
(1992) states that in order to achieve a medium effect size, (at a significance level of 
0.05), with five predictor variables, a sample of 91 participants is required. Harris (1985) 
proposed the following equation to calculate the recommended sample size for a 
regression analysis: N  50 + m (m= the number of predictor variables). There are five 
predictor variables in the present study; therefore, based on Harris’ equation, a total of 
55 participants would be required. Brace et al., (2006) state that the minimum should be 
five times as many participants as predictor variables, but a better ratio is 10:1. As such, 
15 participants were required per predictor variable in this study, and therefore the 
assumption of sufficient participants was met. 
 
Assumption 2: The criterion variable should be drawn from a normally distributed 
population of scores.  
How assessed: The treatment gain scores (criterion variable) were tested for normal 
distribution and were this was not met the data were transformed. Following 
transformation if the data were still not normally distributed non-parametric tests were 
used i.e. Spearman’s Rho.  
 
Assumption 3: Variables should be linearly related to the criterion variable 
How assessed: Multiple correlations were conducted using either Pearson’s or 
Spearman’s Rho depending on whether the data were normally distributed or not. Only 





Assumption 4: Outliers may need to be eliminated 
How assessed: As the group sizes were all less than 100 with the largest being 58 
outliers were not removed. This is based on the fact that outliers cannot be deleted 
simply because they are outliers, and this is particularly important to consider if the 
sample size is less than 100 (Dancey & Reidy, 2004). 
 
Assumption 5: Multicollinearity 
How Assessed: The Tolerance Collinearity statistic was used to assess if the tolerance in 
the amount of variance in the IV was accounted for by the remaining IVs. Tolerance 
levels of .10 or less were considered insufficient and the IV was therefore not included 





















5 THE DRUG AND ALCOHOL EDUCATION GROUP 
The Drug and Alcohol (D&A) Education Group has been developed by the hospital in 
this study as a psycho-educational group, that focuses on the impact of substance misuse 
on the individual. The group runs for ten sessions with each session lasting 
approximately one hour. The following measures are used pre and post treatment as part 
of the service evaluation process to assess participants’ performance in the group:- 
 
The Drug Knowledge Questionnaire (see Appendix 4)  
This measure was developed by the hospital in this study and tests the knowledge 
participants have gained regarding drug misuse. There are 25 items in the measure and 
the participant is asked to tick true/false following each item. A percentage score is then 
calculated via a computerised scoring system. The higher the percentage score the better 
indicating improved knowledge. 
 
The Alcohol Knowledge Questionnaire (see Appendix 5)  
This measure was also developed by the hospital in this study, and tests the knowledge 
participants have gained regarding alcohol misuse. There are 25 items in the measure 
and the participant is asked to tick true/false following each item. A percentage score is 
then calculated via a computerised scoring system and the higher the percentage score 
the better as this indicates increased knowledge. Although both measures have not been 
formally tested for reliability and validity, previous research within the hospital using 
these measures has demonstrated significant findings. Table 5.0 provides some of the 







Table 5.0 Summary of descriptive statistics for the Drug Knowledge Questionnaire and 
Alcohol Knowledge Questionnaire 






N = 58 N = 58 
Mean treatment gain 
score 
1.96 1.97 
Standard Deviation  0.06 0.04 
 
As this data was not normally distributed Spearman’s Rho correlations were conducted 
to determine which cognitive variables were significantly related to the treatment gain 
scores. This was as part of an exploratory analysis and the significant results are 

















Table 5.1 Summary of significant predictor variables for treatment gain scores from 







FSIQ (Full Scale IQ) NS 0.04 







Time t score 
NS 0.02 




Delayed Index Score 
NS 0.01 
Correlations are significant at the 0.05 level (2-tailed). 
NS = Not significant (only significant results are included) 
 
 
5.1 Multiple regression : Drug and Alcohol Education Group 
Table 5.2 provides a summary of the results from multiple regression analysis which 
was used to assess the contribution of the cognitive factors identified above in relation to 








Table 5.2 Summary of results from multiple regression on Drug Knowledge 
Questionnaire  
      










.001 .001 .224 .030 .016 
Full Scale 
IQ 










 7.5 .001  .919  
Each PV was entered in the models described above  
Table 5.2 illustrates that when the PV’s in model 1 were entered into the regression a 
significant result was established as p = .016. This result indicates that the Inattention t 
score and Full scale IQ score together predict treatment gain scores on the Drug 
Knowledge Questionnaire. Furthermore, the Inattention predictor variable alone was 
predictive of treatment gain scores (p=.030).  
Similarly when the PV’s in model 2 were entered a significant result was achieved as p 
= .024. This model indicates that the Auditory Recognition Delayed Index and General 
Memory Index together predict treatment gain scores on the Drug Knowledge 
Questionnaire. However, these predictor variables alone did not predict treatment gain 
scores.  
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As detailed in Table 5.1 there was one significantly correlated variable with the Alcohol 
Knowledge Questionnaire. This was entered into a linear regression and the results are 
shown in the Table 5.3. 
 
Table 5.3 Summary of results from linear regression on Alcohol Knowledge 
Questionnaire  
      







-.007 .006 .015 .232 .232 
 
Table 5.3 indicates that the PV Faces I Recognition Scaled Score is not significant (p = 
.232) and is therefore not predictive of treatment gain scores on the Alcohol Knowledge 
Questionnaire. 
5.2 Summary and Discussion of Findings 
The above results indicate that aspects of memory (General Memory Index and Auditory 
Recognition Delayed Index), along with attention and IQ are significant in predicting 
treatment gain scores in the Drug and Alcohol Education Group. This means that as 
scores improved on cognitive variables so too did treatment gain scores, for example, 
better memory scores resulted in higher treatment gain scores. This is true for the Drug 
Knowledge Questionnaire but not the Alcohol Knowledge Questionnaire, as it did not 
reveal significant results. However, IQ and memory predictor variables were not 
significant individually and only proved significant when part of a multiple regression 
model. Attention was the one variable that did prove significant alone. As this is a 
primarily psycho-educational group involving a more didactic teaching/lecture style, this 
may explain why aspects of memory are predictive of treatment gain scores. Participants 
are required to retain large amounts of information in a relatively short space of time, 
and as the group lasts for a shorter duration (10 weeks) than other groups, there may be 
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less opportunity to practice skills. Similarly, the outcome measures used test participants 
knowledge of the information received during treatment, requiring the ability to attend to 
the material being presented in order to later recall it. These findings would be appear to 
concur with the research cited previously that participants with memory or attention 
deficits may struggle with a psycho-educational approach (Zygmunt et al., 2002). This is 
an important consideration for this type of group, and it may be that a more interactive 
















6 THE DRUG AND ALCOHOL SAYING NO GROUP 
The Drug and Alcohol Saying No Group is a relapse prevention group incorporating 
elements of CBT to identify negative thinking patterns and challenge irrational beliefs. 
The group is based on the cognitive-behavioural relapse prevention model proposed by 
Marlatt and Gordon (1985). The group was adapted from a similar one used in the 
Scottish Prison Service and made more suitable for a mentally disordered population. It 
is run over 28 sessions and is held weekly, each session lasting approximately 2.5 hours. 
The following information describes one of the outcome measures that is used pre and 
post treatment as part of the service evaluation process to assess participants 
performance in the group:- 
The Drug-Taking Confidence Questionnaire (Annis & Martin, 1985) 
The Drug-Taking Confidence Questionnaire (DTCQ) is a 50-item self-report 
questionnaire designed to measure perceived coping self-efficacy in specific situations, 
and can be used with any substance that is misused (e.g., cocaine, heroin, alcohol, and 
cannabis). The individual is asked to rate their confidence in abstaining from their drug 
of choice in 50 different scenarios, on a six point scale (0, 20, 40, 60, 80, 100) ranging 
from 0 (no confidence) to 100 (complete confidence). The higher the score the better as 
this indicates increased confidence in their perceived ability to deal with situations 
involving drugs. If the individual has more than one drug of choice i.e. polysubstance 
misuse, they can rate their confidence for both substances. There are eight subscales 
which measure their confidence in the following areas:- unpleasant emotions (10 items), 
physical discomfort (5 items), pleasant emotions (5 items), testing personal control (5 
items), urges and temptations to use (5 items), conflict with others (10 items), social 
pressure to use (5 items), and pleasant times with others (5 items). The eight subscales of 
the DTCQ have demonstrated good reliability (alphas .79 to .95) and validity (Sklar et 
al., 1997). As the measure is administered via computer it is not possible to provide an 
example in the appendices. 
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6.1 Multiple regression: Drug and Alcohol Saying No Group 
Table 6.0 outlines descriptive statistics for the DTCQ measure. The data that is normally 
distributed contains minus values for mean scores, however this indicates an increase in 
scores from pre to post treatment, i.e. a positive treatment gain score. 
Table 6.0 Descriptive statistics for the Drug Taking Confidence Questionnaire (DTCQ)  
DTCQ Subscale Number 
completed (N) 
Mean treatment gain 





43 1.83 .303 
Physical 
Discomfort 
43 1.85 .251 
Pleasant 
Emotions 
42 1.86 .192 
Testing Control 44 -25.14 37.04 
Urge to Use 43 1.80 .296 
Conflict 43 1.82 .346 
Social Pressure 42 1.79 .371 
Pleasant Times 44 1.76 .387 
Unpleasant 
Emotions 2 
21 -31.57 27.41 
Physical 
Discomfort 2 
21 -25.52 27.34 
Pleasant 
Emotions 2 
21 -26.33 27.03 
Testing Control 2 21 -25.29 24.35 
Urge to Use 2 23 -24.04 37.33 
Conflict 2 21 -29.48 27.01 
Social Pressure 2 21 -35.86 29.29 
Pleasant Times 2 21 -28.62 23.79 
Italics indicate data that is normally distributed 
The number 2 indicates individuals with poly substance misuse who rated both substances 
 
 66 
Tables 6.1 to 6.7 provide a summary of the results from correlations which were 
conducted to assess the contribution of cognitive factors in relation to participants’ 
treatment gain scores on the Drug Taking Confidence Questionnaire (DTCQ). Only 
significant results are reported and any data that was not normally distributed following 
transformation, the non-parametric equivalent test was used. Correlations were not 
performed for the second type of drug an individual used as this was not their primary 
drug of choice, and therefore not the most important substance. The number of 
individuals with poly substance misuse was also reduced, n = 21 meaning results from 
such a small sample would not be reliable. 
 
Table 6.1 Summary of cognitive predictor variables significantly related to the DTCQ 
Unpleasant Emotions Subscale 
Cognitive Predictor variables Spearman’s Rho Correlation Sig for 
DTCQ Unpleasant Emotions Subscale 
Verbal Recall I Scaled Score (SS) .014 
Verbal Recall II SS .027 
SCOLP Spot the Word Test (SWT) SS .019 
SCOLP Speed of Comprehension Test 
(SCT) SS 
.034 
Correlations are significant at the 0.05 level (2-tailed). 
 
 
Table 6.2 Summary of cognitive predictor variables significantly related to the DTCQ 
Physical Discomfort Subscale 
Cognitive Predictor variables Spearman’s Rho Correlation Sig for 
DTCQ Physical Discomfort Subscale 
Processing Speed Index .029 
Verbal IQ Actual Difference .031 




Table 6.3 Summary of cognitive predictor variables significantly related to the DTCQ 
Pleasant Emotions Subscale 
Cognitive Predictor variables Spearman’s Rho Correlation Sig for 
DTCQ Pleasant Emotions Subscale 
Response Style t score .016 
Response Style Percentile .008 
Correlations are significant at the 0.05 level (2-tailed). 
 
 
Table 6.4 Summary of cognitive predictor variables significantly related to the DTCQ 
Testing Control Subscale 
Cognitive Predictor variables Pearson’s Correlation Sig for DTCQ 
Testing Control Subscale 
Picture Arrangement SS .047 
Working Memory Index .03 
Correlations are significant at the 0.05 level (2-tailed). 
 
 
Table 6.5 Summary of cognitive predictor variables significantly related to the DTCQ 
Urge to Use Subscale 
Cognitive Predictor variables Spearman’s Rho Correlation Sig for 
DTCQ Urge to Use Subscale 
Verbal Recall I SS .013 
Full Scale IQ actual difference .029 







Table 6.6 Summary of cognitive predictor variables significantly related to the DTCQ 
Social Pressure Subscale 
Cognitive Predictor variables Spearman’s Rho Correlation Sig for 
DTCQ Social Pressure Subscale 
Inattention Commission t score .009 
Inattention Commission Percentile .01 
Inattention Detectability t score .025 
Inattention Detectability Percentile .025 
Verbal Recall I SS .047 
Correlations are significant at the 0.05 level (2-tailed). 
 
 
Table 6.7 Summary of cognitive predictor variables significantly related to the DTCQ 
Pleasant Times Subscale 
Cognitive Predictor variables Spearman’s Rho Correlation Sig for 
DTCQ Pleasant Times Subscale 
Inattention Omission t score .047 
Verbal Recall I SS .034 
Immediate Memory Index .01 
SCOLP SCT SS .026 
Attention Deficit Confidence Index .025 
FSIQ actual difference .046 
Inattention variance t score .025 
Inattention variance percentile .024 
Correlations are significant at the 0.05 level (2-tailed). 
 
 
Following correlational analyses the significantly related variables were entered into a 
regression model. Tables 6.8 to 6.14 provide a summary of the results from multiple 
regression analysis which was used to assess the contribution of the predictor variables 
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i.e. cognitive factors in relation to participants’ treatment gain scores on the various 
subscales of the Drug Taking Confidence Questionnaire:-  
Table 6.8 Summary of results from multiple regression on the Unpleasant Emotions 
Subscale of the Drug Taking Confidence Questionnaire  
      




Model 1 – 
SCOLP Speed of 
Comprehension 
Test SS 
-.011 .05 .032 .823 .285 
SCOLP Spot the 
Word Test SS 
 -.049 .042  .259  
Model 2 –Verbal 
1 Recall SS 
 -.090 .045 .083 .062 .162 
Verbal II Recall 
SS 
 .042 .034  .233  
Each PV was entered in the models described above  
 
Table 6.8 indicates that none of the predictor variables individually or collectively in 
model one and two were significant in predicting treatment gain scores on the 
Unpleasant Emotions subscale of the DTCQ. 
 
Table 6.9 Summary of results from multiple regression on the Physical Discomfort 
Subscale of the Drug Taking Confidence Questionnaire  
      




Model 1 – 
Processing 
Speed Index 




 -.003 .005  .466  
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Table 6.9 indicates that none of the predictor variables individually or collectively in 
model one were significant in predicting treatment gain scores on the Physical 
Discomfort subscale of the DTCQ. 
 
Table 6.10 Summary of results from multiple regression on the Pleasant Emotions 
Subscale of the Drug Taking Confidence Questionnaire  
      




Model 1 – 
Response 
Style t score 
-.002 .002 -.003 .122 .343 
 
Table 6.10 indicates that the predictor variable Response Style t score was not a 
significant variable in predicting treatment gain scores on the Pleasant Emotions 
subscale of the DTCQ. 
 
Table 6.11 Summary of results from multiple regression on the Testing Control Subscale 
of the Drug Taking Confidence Questionnaire  
      




Model 1 – 
Picture 
Arrange SS 




 .803 .985  .424  
 
 
Table 6.11 indicates that none of the predictor variables individually or collectively in 
model one were significant in predicting treatment gain scores on the Testing Control 
subscale of the DTCQ. 
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Table 6.12 Summary of results from multiple regression on the Urge to Use Subscale of 
the Drug Taking Confidence Questionnaire  
      




Model 1 – 
FSIQ actual 
difference 
-.003 .005 -.030 .572 .510 
Verbal I 
Recall SS 
 -.015 .024  .546  
 
 
Table 6.12 indicates that none of the predictor variables individually or collectively in 
model one were significant in predicting treatment gain scores on the Urge to Use 
subscale of the DTCQ. 
 
 
Table 6.13 Summary of results from multiple regression on the Social Pressure Subscale 
of the Drug Taking Confidence Questionnaire  
 
      






Model 1 – Inattention 
Commission t score 
.048 .023 .118 .048 .134 
Inattention Detectability t score 
 





































Table 6.13 indicates that the only significant predictor variable was the Inattention 
Commission t score. However, when entered into the regression model with another 
variable the model did not prove significant. Model 2 was also not significant in 
predicting treatment gain scores on the Social Pressure subscale of the DTCQ. 
 
Table 6.14 Summary of results from multiple regression on the Pleasant Times Subscale 
of the Drug Taking Confidence Questionnaire  
 
      




Model 1 – 
Inattention 
Omission t score 
.002 .003 .085 .440 .167 






Variability t score 
Model 3 - 
Attention Deficit 
Confidence Index 






















































































Each PV was entered in the models described above  
 
Table 6.14 indicates that the only significant predictor variable was the SCOLP SCT 
scaled score (p= .014). When entered into the regression model with another predictor 
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variable the result was significant (p= .032). The other predictor variables and models 
were not significant in either individually or collectively predicting treatment gain scores 
on the Pleasant times subscale of the DTCQ. 
 
6.2 Summary and Discussion of Findings 
The above results indicate that aspects of attention and executive functioning were 
significant at predicting treatment gain scores on the DTCQ. Although several other IQ 
and memory variables were correlated to DTCQ subscales, they did not prove to be 
significantly predictive of outcome scores. This means that as inattention levels 
increased so too did treatment gain scores on the DTCQ which is not the direction of 
association that may have been expected. However, the relationship was negative for 
executive functioning meaning that as treatment gain scores increased executive 
functioning scores decreased. This is a positive result indicating that the less executive 
functioning difficulties an individual has the more they can benefit from treatment. The 
DTCQ measure assesses an individual’s confidence of abstaining from substances in 
various different scenarios, and it may be that cognitive skills of attention and 
planning/processing speed are more relevant in this task. For example, paying attention 
to the scenario being outlined and planning/imagining how you would react in such a 
situation, are skills which require attention and executive functioning.       
  
The Drug and Alcohol Saying No group itself is a much longer CBT based group than 
the Drug and Alcohol Education group, requiring participants to engage in behavioural 
activities such as role-play and group exercises. It may be that this behavioural 
component to the group requires skills of attention and executive functioning more than 
memory and IQ, resulting in these cognitive variables being predictive of treatment gain. 
This would concur with previous research cited in section 1.5.1 on prison inmates which 
found executive functioning and emotion regulation were predictive of treatment 
outcome following a nine month CBT programme (Fishbein et al., 2006). The Saying 
No group lasts for a similar period of time and is also CBT based. 
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7 THE COPING WITH MENTAL ILLNESS GROUP 
This is a psycho-educational group which aims to teach individuals’ who suffer from 
mental health difficulties about their illness and other related disorders. It was developed 
by staff within the hospital in this study to assist patients’ in understanding their illness 
and the implications it has for their detention. The content of the programme is based on 
principles of Psychosocial Intervention (PSI), which is an evidence-based approach for 
people with schizophrenia.  The group is run for 22 sessions each lasting one hour and is 
split into three modules; foundation, the legal system and coping skills and recovery. 
The following measures are administered pre and post treatment:- 
 
Forensic Assessment of Knowledge Tool (FAKT) (Walker, Connaughton & Wilson, 
2005) 
This measure (see Appendix 6) assesses the patient’s understanding of their symptoms 
and management of their illness, as well as legal issues. As it was developed by staff 
within the hospital in this study it has not been validated, however previous research 
within the hospital using this measure has demonstrated significant findings. A total 
score out of a possible 50 is calculated with higher scores indicating greater knowledge. 
 
Understanding of Medication Questionnaire (MacPherson, 1995)  
This measure (see Appendix 7) assesses an individual’s understanding of their treatment 
for schizophrenia, why they have been prescribed medication and the effects it can have 
on them. There are ten items, which are scored 0, 1 or 2 giving a total score out of 35 
with high scores indicating greater understanding. Previous research with a 
schizophrenic population has yielded significant findings using this measure 
(Macpherson et al., 1996). However, there does not appear to be evidence regarding the 






7.1 Multiple Regression: Coping With Mental Illness (CWMI) Group 
Table 7.0 outlines descriptive statistics for the Understanding of Medication and FAKT 
measures. A minus value for mean score indicates an increase in scores from pre to post 
treatment, i.e. a positive treatment gain score.  
Table 7.0 Descriptive statistics for the Coping With Mental Illness Group 
 Understanding of 
Medication Questionnaire 











Italics indicate data that is NOT normally distributed 
 
Tables 7.1 and 7.2 provide a summary of the results from correlations which were 
conducted to assess the contribution of cognitive factors in relation to participants’ 
treatment gain scores on the Understanding of Medication Questionnaire and the FAKT. 
Only significant results are reported and any data that were not normally distributed 
following transformation, the non-parametric equivalent test was used. 
 
Table 7.1 Summary of cognitive predictor variables significantly related to the 
Understanding of Medication Questionnaire 
Cognitive Predictor variables Pearson’s Correlation Sig for 
Understanding of Medication 
Questionnaire 
Picture Completion Scaled Score .03 
Attention Deficit Confidence Index .008 
Correlations are significant at the 0.05 level (2-tailed). 
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Table 7.2 Summary of cognitive predictor variables significantly related to the Forensic 
Assessment of Knowledge Tool (FAKT) 
Cognitive Predictor variables Spearman’s Rho Correlation Sig for 
Forensic Assessment of Knowledge Tool 
Response Style t score .009 
Response Style percentile .009 
Intra-Extra Dimensional Set Shift (IED) 
total errors SS 
.04 
Arithmetic SS .032 
Verbal Recall I SS .011 
Verbal Recall II SS .029 
Correlations are significant at the 0.05 level (2-tailed). 
 
Due to the small sample size of the FAKT group it was not possible to conduct multiple 
regression. As stated previously some data were either missing or incomplete and this 
resulted in reduced full data sets for this measure. Therefore Table 7.3 demonstrates the 
results of regression analyses on the Understanding of Medication group:- 
 
Table 7.3 Summary of results from multiple regression on the Understanding of 
Medication Questionnaire 
      













 -.097 .040  .029  
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Table 7.3 indicates that both predictor variables individually and collectively in model 
one were significant in predicting treatment gain scores on the Understanding of 
Medication Questionnaire. The overall model was highly significant at p = .007 and the 
predictor variable Picture Completion Scaled Score was significant at p= .018, along 
with the Attention Deficit Confidence Index significant at p= .029. 
 
7.2 Summary and Discussion of Findings 
The above results indicate that both attention and IQ cognitive variables were significant 
in predicting treatment outcome scores on the Understanding of Medication 
questionnaire. However, this was a negative relationship meaning that as treatment gain 
scores increased attention and IQ scores decreased. This is a similar finding to the Drug 
and Alcohol Education group as discussed previously, although memory was not found 
to be a significant predictor variable in the CWMI group. The CWMI group is also 
primarily psycho-educational and this may be part of the reason for the similar results 
from the two groups. The fact that memory did not appear to be a significant predictor 
variable in this group may be related to the small sample size and the fact that as a result 
of this, regression analysis was only conducted on one measure in comparison to two 














8 THE SOCIAL PROBLEM SOLVING ‘TAKE CONTROL’ GROUP 
This group was developed by adapting existing problem solving skills programmes and 
modifying them for a mentally disordered population. The main programme basis came 
from the Reasoning and Rehabilitation (R&R) programme (Ross et al., 1988), which is 
one of the most widely delivered CBT programmes for offenders in over 17 countries 
(Ross, 2004). The aim is to teach not only problem solving and self management, but 
critical and moral reasoning, creative thinking and social skills training.   
 
There are several measures administered pre and post treatment as part of the service 
evaluation process, and the following measures were selected for this study:- 
 
Social Problem Solving Inventory (SPSI)(D’zurilla et al., 2002)(see Appendix 8) 
This is a 25 item self-report measure which assesses an individual’s attitudes towards 
solving problems and is based on general functioning.  The scale measures:- 
 Positive problem orientation (how much an individual appraises a problem as a 
challenge, believes they are solvable and commits to solving them). A high score 
on this subscale indicates a positive approach to problem solving. 
 Negative problem orientation (how much an individual views a problem as a 
threat to well being, doubts their ability to solve problems and the degree to 
which they become upset when confronted with a problem). A low score on this 
subscale indicates the ability to avoid becoming upset by problems. 
 Rational problem solving (how much an individual utilises a rational and 
deliberate effective problem solving strategy when faced with a problem). A high 
score on this subscale indicates good rational problem solving skills. 
 Impulsivity/carelessness style. A low score on this subscale indicates a lack of 
impulsivity and carelessness in problem solving.  
 Avoidance style. A low score on this subscale indicates a lack of avoidance in 
problem solving. 
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Raw scores are converted into standard scores for each subscale as well as an overall 
total score. Internal consistency is strong and stable over time ranging from 0.69 - 0.93, 
and reliability measurements ranged from 0.72 - 0.84 (D’Zurilla et al., 2002).  
 
The Coping Responses Inventory (Moos, 1993)(see Appendix 9)  
This is a self-report measure assessing different types of responses to stressful life 
circumstances.  The scales are divided in to approach coping (problem–focused) and 
avoidance coping (emotion focused), reflecting cognitive and behavioural efforts to 
either resolve life stressors or to avoid thinking about them. 
 
This scale measures: 
 Logical Analysis: the degree to which an individual cognitively attempts to 
understand and prepare mentally for a stressor and its consequences (high scores 
indicate good logical analysis capability) 
 Positive Reappraisal: the degree to which an individual cognitively attempts to 
restructure a problem in a positive way, while still accepting the reality of the 
situation (high scores indicate increased positive reappraisal) 
 Seeking Guidance and Support: the degree to which an individual behaviourally 
attempts to seek information, guidance and support (high scores are positive 
indicating increased seeking of guidance and support) 
 Problem Solving: the degree to which an individual behaviourally attempts to 
take action to deal directly with a problem (high scores indicate increased 
problem solving capabilities) 
 Cognitive Avoidance: the degree to which an individual cognitively attempts to 
avoid thinking realistically about a problem (low scores indicate a lack of 
cognitive avoidance) 
 Acceptance or resignation: the degree to which an individual cognitively 
attempts to react to the problem by accepting it (low scores indicate a lack of 
acceptance or resignation) 
 80 
 Seeking Alternative Rewards: the degree to which an individual behaviourally 
attempts to get involved in substitute activities and create new sources of 
satisfaction (low scores indicate a lack of seeking alternative rewards) 
 Emotional Discharge: the degree to which an individual behaviourally attempts 
to reduce tension by expressing negative feelings (low scores indicate a lack of 
emotional discharge) 
 
Raw scores are converted into T scores for each subscale and there is no total score on 
this measure. Internal consistency for the eight scales in a male population is moderate 
ranging from 0.61 to 0.74 (Moos, 1993).   
 
The Barratt Impulsivity Scale(BIS)(Patton et al., 1995)(see Appendix 10)  
This is a 30 item self-report scale split into three subscales which measures:- 
 Motor Impulsiveness (a high score indicates the individual acts without thinking 
therefore low scores are better)  
 Cognitive Impulsiveness (a high score indicates the individual makes quick 
cognitive decisions therefore low scores are better) 
 Non planning Impulsiveness (a high score indicates the individual is neither 
concerned about or makes plan for the future, therefore low scores are better) 
The three subscales, each containing 10 items, are totaled to give a score for each 
subscale. Internal consistency ranges from 0.79 to 0.83 for various populations ranging 
from under-graduates, substance-abuse patients, general psychiatric patients, and prison 
inmates (Patton et al., 1995). 
8.1 Multiple Regression: Social Problem Solving ‘Take Control’ Group 
Table 8.0 outlines descriptive statistics for the Coping Responses Inventory. A minus 
value for mean score indicates an increase in scores from pre to post treatment, i.e. a 
positive treatment gain score.  
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Table 8.0 Descriptive statistics for the Coping Responses Inventory (CRI) 








Logical Analysis 47 2.01 .059 
Positive Reappraisal 45 -0.4 4.277 
Seeking Guidance and 
Support 
45 -0.76 5.331 
Problem Solving 45 2.00 .02 
Cognitive Avoidance 45 0.96 4.426 
Acceptance or resignation 45 0.38 4.589 
Seeking Alternative 
Rewards 
46 2.01 0.049 
Emotional Discharge 45 2.0 0.014 
Italics indicate data that is NOT normally distributed 
 
Tables 8.1 to 8.5 provide a summary of the results from correlations which were 
conducted to assess the contribution of cognitive factors in relation to participants’ 
treatment gain scores on the subscales of the Coping Responses Inventory. Only 
significant results are reported and any data that was not normally distributed following 













Table 8.1 Summary of cognitive predictor variables significantly related to the Logical 
Analysis Subscale of the Coping Responses Inventory 
Cognitive Predictor variables 
 
Spearman’s Rho Correlation Sig for 
Logical Analysis Subscale 
Logical memory I SS .001 
Logical memory II SS .001 
Immediate Memory Index .001 
General Memory Index .003 
Auditory Immediate Memory Index .003 
Auditory Delayed Memory Index .008 
Family Recall II SS .013 
Visual Delayed Memory Index .014 
Attention Deficit Confidence Index .025 
Visual Immediate Memory Index .026 
Family Recall I SS .038 
FSIQ actual difference .049 
Impulsivity  t score .049 
Correlations are significant at the 0.05 level (2-tailed). 
 
Table 8.2 Summary of cognitive predictor variables significantly related to the Positive 
Reappraisal Subscale of the Coping Responses Inventory 
Cognitive Predictor variables Pearson’s Correlation Sig for Positive 
Reappraisal Subscale 
Logical Memory I Scaled Score .004 






Table 8.3 Summary of cognitive predictor variables significantly related to the 
Cognitive Avoidance Subscale of the Coping Responses Inventory 
Cognitive Predictor variables Pearson’s Correlation Sig for Cognitive 
Avoidance Subscale 
Verbal Recall II Scaled Score .028 
Inattention t score .026 
Response Style t score .036 
Correlations are significant at the 0.05 level (2-tailed). 
 
Table 8.4 Summary of cognitive predictor variables significantly related to the Seeking 
Alternative Rewards Subscale of the Coping Responses Inventory 
Cognitive Predictor variables Spearman’s Rho Correlation 
Sig for Seeking Alternative 
Rewards Subscale 
Inattention Response Time Standard Error t score .039 
Inattention Response Time Standard Error 
percentile 
.026 
Inattention Variability t score .040 
Inattention change t score .020 
Inattention change percentile .018 
Vigilance Response Time block change t score .019 
Vigilance Response Time block change percentile .019 
Vigilance Standard Error block change t score .002 
Vigilance Standard Error block change percentile .004 









Table 8.5 Summary of cognitive predictor variables significantly related to the 
Emotional Discharge Subscale of the Coping Responses Inventory 
Cognitive Predictor variables Pearson’s Correlation Sig for Emotional 
Discharge Subscale 
SCOLP Spot the Word Test Scaled Score .042 
Correlations are significant at the 0.05 level (2-tailed). 
 
Following correlational analysis the significantly related variables were entered into a 
regression model. Tables 8.6 to 8.10 provide a summary of the results from multiple 
regression analyses which was used to assess the contribution of the predictor variables 
i.e. cognitive factors in relation to participants’ treatment gain scores on the various 
















Table 8.6 Summary of results from multiple regression on the Logical Analysis Subscale 
of the Coping Response Inventory 
      




Model 1 – Impulsivity t 
score 
.000 .001 .192 .774 .087 
Attention Deficit 
Confidence Index 
FSIQ actual difference 
Model 2 –  Logical 
Memory Recall I SS  
Family Recall I SS 
Logical Memory Recall 
II SS 
Model 3 – Family 









































































































































Each PV was entered in the model described above  
 
Table 8.6 indicates that in Model 1 the predictor variables individually and collectively 
were not significant in predicting treatment gain scores on the Logical Analysis Subscale 
of the CRI. In Model 2 the predictor variables individually were not significant but 
collectively were significantly predictive (p = .015). In Model 3 this was again the case 
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with the individual predictor variables not producing significant results but the overall 
model proving significant (p = .029). Model 4 and 5 were again significant in predicting 
treatment gain scores on the Logical Analysis subscale of the CRI, and the General 
Memory Index predictor variable in Model 5 was individually significant at p = .006. 
 
Table 8.7 Summary of results from linear regression on the Positive Reappraisal 
Subscale of the Coping Response Inventory 
      








.615 .197 .231 .004 .004 
 
Table 8.7 indicates that the predictor variable Logical Memory I Scaled Score is 
significant in predicting treatment gain scores on the Positive Reappraisal subscale of 
the CRI.  
 
Table 8.8 Summary of results from multiple regression on the Cognitive Avoidance 
Subscale of the Coping Response Inventory 
      




Model 1 – 
Verbal 





























Table 8.8 indicates that the predictor variable Verbal Recall II Scaled Score is 
significant in predicting treatment gain scores on the Cognitive Avoidance subscale of 
the CRI. Furthermore, the model as a whole also proved significant with p = .013. 
 
Table 8.9 Summary of results from multiple regression on the Seeking Alternative 
Rewards Subscale of the Coping Response Inventory 
      




Model 1 – 
Inattention 
Standard 
Error t score 




Model 2 –  
Inattention 
change t score  
Vigilance 
Response 
Time T score 
Vigilance 
Standard 



























































Each PV was entered in the model described above  
 
Table 8.9 indicates that in Model 1 none of the predictor variables were significant 
individually, but collectively they were significant in predicting treatment gain scores on 
the Seeking Alternative Rewards subscale of the CRI (p= .045). In model 2 the predictor 




Table 8.10 Summary of results from multiple regression on the Emotional Discharge 
Subscale of the Coping Response Inventory 
      









.038 .018 .055 .042 .042 
 
Table 8.10 indicates that the predictor variable SCOLP SWT Scaled Score is significant 
in predicting treatment gain scores on the Emotional Discharge subscale of the CRI (p = 
.042).  
 
8.2 Social Problem Solving Inventory 
Table 8.11 outlines descriptive statistics for the Social Problem Solving Inventory. A 
minus value for mean score indicates an increase in scores from pre to post treatment, 
i.e. a positive treatment gain score.  
Table 8.11 Descriptive statistics for the Social Problem Solving Inventory (SPSI) 








46 -0.41 3.739 
Negative Problem 
Orientation 
46 2.0 0.025 
Rational Problem 
Solving 
47 -2.02 4.331 
Impulsivity Style 47 0.55 4.854 
Avoidance Style 47 2.00 0.02 
Total Score 48 2.00 0.081 
Italics indicate data that is NOT normally distributed 
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Tables 8.12 to 8.17 provide a summary of the results from correlations which were 
conducted to assess the contribution of cognitive factors in relation to participants’ 
treatment gain scores on the subscales of the Social Problem Solving Inventory (SPSI). 
Only significant results are reported and any data that was not normally distributed 
following transformation, the non-parametric equivalent test was used. 
 
Table 8.12 Summary of cognitive predictor variables significantly related to the Positive 
Problem Orientation Subscale of the SPSI  
Cognitive Predictor variables Pearson’s Correlation Sig for Positive Problem 
Orientation Subscale 
Auditory Recognition Delayed 
Index 
.007 
CANTAB Rapid Visual Information 
Processing SS 
.045 
Immediate Memory Index .022 
General Memory Index .035 
Correlations are significant at the 0.05 level (2-tailed). 
 
Table 8.13 Summary of cognitive predictor variables significantly related to the 
Negative Problem Orientation Subscale of the SPSI  
Cognitive Predictor variables Spearman’s Rho Correlation Sig for 
Negative Problem Orientation Subscale 
Impulsivity Perseveration t score .015 
Impulsivity Perseveration percentile .038 
Vigilance Standard Error change t score .013 
Vigilance Standard Error change percentile .012 
Attention Deficit Confidence Index .048 
Big/Little Circle  % correct .024 
Faces II Recognition SS .048 
Correlations are significant at the 0.05 level (2-tailed). 
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Table 8.14 Summary of cognitive predictor variables significantly related to the 
Rational Problem Solving Subscale of the SPSI  
Cognitive Predictor variables Pearson’s Correlation Sig for Rational 
Problem Solving Subscale 
Inattention Commission Percentile .007 
Inattention Detectability t score .024 
Inattention Detectability Percentile .017 
Response Style Percentile .014 
Correlations are significant at the 0.05 level (2-tailed). 
 
Table 8.15 Summary of cognitive predictor variables significantly related to the 
Impulsivity Style Subscale of the SPSI  
Cognitive Predictor variables Pearson’s Correlation Sig for 
Impulsivity Style Subscale 
Stockings Of Cambridge (SOC) Task 
mean subsequent time SS  
.042 
Impulsivity perseveration t score .019 
SOC mean initial Time SS .049 
Correlations are significant at the 0.05 level (2-tailed). 
 
Table 8.16 Summary of cognitive predictor variables significantly related to the 
Avoidance Style Subscale of the SPSI  
Cognitive Predictor variables Spearman’s Rho Correlation Sig for 
Avoidance Style Subscale 
Impulsivity Perseveration t score .008 
Impulsivity Perseveration percentile .005 
SOC mean initial Time SS .022 




Table 8.17 Summary of cognitive predictor variables significantly related to the Total 
Score Subscale of the SPSI  
Cognitive Predictor variables Spearman’s Rho Correlation Sig for 
Total Score Subscale 
SOC mean initial Time SS .019 
Information Scaled Score .021 
Correlations are significant at the 0.05 level (2-tailed). 
 
 
Following correlational analyses the significantly related variables were entered into a 
regression model. Tables 8.18 to 8.23 provide a summary of the results from multiple 
regression analyses which were used to assess the contribution of the predictor variables 
i.e. cognitive factors in relation to participants’ treatment gain scores on the subscales of 
the SPSI:-  
 
 
Table 8.18 Summary of results from multiple regression on the Positive Problem 
Orientation Subscale of the SPSI 
      





























































Each PV was entered in the model described above  
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Table 8.18 indicates that in Model 1 both predictor variables were significant and the 
overall model was also significant in predicting treatment gain scores on the Positive 
Problem Orientation subscale of the SPSI (p = .011). However Model 2 was not 
significant overall and neither predictor variables individually were significant. 
 
 
Table 8.19 Summary of results from multiple regression on the Negative Problem 
Orientation Subscale of the SPSI 
      
























































































Each PV was entered in the model described above  
 
 
Table 8.19 indicates that both models are significant in predicting treatment gain scores 
on the Negative Problem Orientation Subscale of the SPSI. Furthermore three of the 
predictor variables were also significant individually i.e. Impulsivity Perseveration t 
score (p=.006), BLC % correct (p=.003) and Faces II Recognition SS (p=.045).  
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Table 8.20 Summary of results from multiple regression on the Rational Problem 
Solving Subscale of the SPSI 
      















































Each PV was entered in the model described above  
 
Table 8.20 indicates that the model is just short of being significant in predicting 
treatment gain scores on the Rational Problem Solving Subscale of the SPSI (p=.055). 
None of the predictor variables were significant individually. 
 
Table 8.21 Summary of results from multiple regression on the Impulsivity Style 
Subscale of the SPSI 
      



































































Table 8.21 indicates that all the predictor variables individually were significant at 
predicting treatment gain scores on the Impulsivity Style subscale of the SPSI. 
Furthermore, both models were also significant with Model 1 p=.002 and Model 2 
p=.049. 
 
Table 8.22 Summary of results from multiple regression on the Avoidance Style 
Subscale of the SPSI 
      







































Table 8.22 indicates that both predictor variables were significant at predicting treatment 
gain scores on the Avoidance Style subscale of the SPSI. However, the model as a whole 
was also significant with p=.000.  
 
Table 8.23 Summary of results from multiple regression on the Total Score Subscale of 
the SPSI 
      










































Table 8.23 indicates that neither the predictor variables individually or collectively were 
significant in predicting treatment gain scores on the Total Score Subscale of the SPSI. 
 
 
8.3 The Barratt Impulsivity Scale 
Table 8.24 outlines descriptive statistics for the Barratt Impulsivity Scale.  
Table 8.24 Descriptive statistics for the Barratt Impulsivity Scale (BIS) 








33 1.0 4.43 
Motor Impulsiveness 33 1.39 4.123 
Cognitive 
Impulsiveness 
33 2.00 0.019 
Total Score 33 2.00 0.063 
Italics indicate data that is NOT normally distributed 
 
 
Tables 8.25 to 8.28 provide a summary of the results from correlations which were 
conducted to assess the contribution of cognitive factors in relation to participants’ 
treatment gain scores on the subscales of the Barratt Impulsivity Scale (BIS). Only 
significant results are reported and any data that was not normally distributed following 









Table 8.25 Summary of cognitive predictor variables significantly related to the Non 
Planning Impulsiveness subscale of the BIS  
Cognitive Predictor variables Pearson’s Correlation Sig for Non 
Planning Impulsiveness Subscale 
Stockings of Cambridge (SOC) Task mean 
subsequent time SS  
.036 
Correlations are significant at the 0.05 level (2-tailed). 
 
 
Table 8.26 Summary of cognitive predictor variables significantly related to the Motor 
Impulsiveness subscale of the BIS  
Cognitive Predictor variables Pearson’s Correlation Sig for Motor 
Impulsiveness Subscale 
SOC Problems Solved SS  .033 
Correlations are significant at the 0.05 level (2-tailed). 
 
 
Table 8.27 Summary of cognitive predictor variables significantly related to the 
Cognitive Impulsiveness subscale of the BIS  
Cognitive Predictor variables Spearman’s Rho Correlation Sig for 
Cognitive Impulsiveness Subscale 
Inattention change t score  .043 
Inattention change percentile .044 
CANTAB Rapid Visual Information 
Processing SS 
.024 







Table 8.28 Summary of cognitive predictor variables significantly related to the Total 
Score subscale of the BIS  
Cognitive Predictor variables Spearman’s Rho Correlation Sig for 
Total Score Subscale 
General Memory Index  .040 
Auditory Delayed Index .018 
Correlations are significant at the 0.05 level (2-tailed). 
 
 
Based on the above correlation analyses the significantly related variables were entered 
into a regression model. Tables 8.29 to 8.32 provide a summary of the results from 
multiple regression analyses which were used to assess the contribution of the predictor 
variables i.e. cognitive factors in relation to participants’ treatment gain scores on the 
various subscales of the BIS:-  
 
Table 8.29 Summary of results from linear regression on the Non planning 
Impulsiveness Subscale of the BIS 
      







































Table 8.29 indicates that the predictor variable SOC mean subsequent time SS is 
significant in predicting treatment gain scores on the Non Planning Impulsiveness 
subscale of the BIS. 
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Table 8.30 Summary of results from linear regression on the Motor Impulsiveness 
Subscale of the BIS 
      




Model 1 – 
Stockings Of 
Cambridge (SOC) 



























Table 8.30 indicates that the predictor variable SOC problems solved SS is significant in 
predicting treatment gain scores on the Motor Impulsiveness subscale of the BIS. 
 
 
Table 8.31 Summary of results from multiple regression on the Cognitive Impulsiveness 
Subscale of the BIS 
      









































Table 8.31 indicates that none of the predictor variables were significant in model 1 




Table 8.32 Summary of results from multiple regression on the Total Score Subscale of 
the BIS 
      













































Table 8.32 indicates that the model was almost significant at p=.051 but fails to reach 
significance and is therefore not predictive. 
 
8.4 Summary and Discussion of Findings 
The results above indicate that memory, attention and executive functioning were all 
significant predictor variables in regression models for the various treatment outcome 
scores in the Social Problem Solving Group. Memory and attention predictor variables 
appeared to be the most frequent significant predictor variables for the Coping Response 
Inventory. Executive functioning was a significant predictor variable for the emotional 
discharge subscale of the CRI, which concurs with the findings of previous research 
highlighting the role of executive functioning and emotion regulation in treatment 
outcome. 
 
Memory, attention and executive functioning were again significant predictor variables 
for the SPSI treatment gain scores. On the Impulsivity subscale of the SPSI the predictor 
variable Impulsivity t score was highly predictive, indicating a strong relationship 
between this cognitive measure of attention, and the outcome measure of impulsiveness 
on the SPSI. 
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Only executive functioning was a significant predictor variable for the BIS treatment 
gain scores. Although correlated to treatment outcome scores, attention and memory 
predictor variables did not prove significant when entered into the regression model. In 
the Non-planning Impulsiveness scale, executive functioning, specifically the Stockings 
of Cambridge task which is a spatial planning task, was a significant predictor variable. 
It would appear that again the predictor variable and outcome measure, both involving 

























9 THE ANGER MANAGEMENT GROUP 
The Anger Management Group is based on the cognitive-behavioural model of anger 
proposed by Novaco (1994). The hospital in this study developed the programme in 
consultation with Professor Ray Novaco. The group consists of an initial preparatory 
stage involving assessment and motivational work, following by eight sessions on 
understanding anger, eight sessions on managing anger and a final four sessions on 
relapse prevention. In total therefore, the group consists of 20 sessions each lasting 
approximately 2.5 hours. The following measures were selected for this study as 
discussed in section 3.4.1, from the battery that are administered pre and post treatment:-    
 
Novaco Anger Scale and Provocation Inventory (NAS-PI)(Novaco, 1994)(see Appendix 
11) 
This measure is composed of two parts, a 60 item self-report measure containing 
Cognitive, Arousal, Behavioral and Anger Regulation subscales, which comprise a Total 
score for anger disposition. High scores indicate problems with anger apart from the 
anger regulation scale where high scores reflect the individual’s perceived ability to 
regulate their own anger i.e. high scores are good in this subscale. The Provocation 
Index consists of 25 items that describe the type of situations that produce anger in an 
individual, and high scores indicate numerous situations provoke anger. The NAS-PI 
was developed and validated for use with mentally disordered as well as normal 
populations. The NAS Total score subscale was found to produce a reliability score of 
.95 and a test-retest (two-weeks) reliability of .84 in research with psychiatric patients 
(Novaco, 1994).  
 
The Imaginal Provocation Test (Novaco, 1975)(see Appendix 12) 
This is a 40 item self-report measure in which an individual is presented with four 
different scenarios, and asked to rate on a scale from 1-4 how they would feel regarding 
this situation. Scores are split into separate indices i.e. anger reaction, behavioural 
reaction, anger composite, anger regulation and memory recall.  High scores in the first 
three indices indicate problems with anger, whereas high score in anger regulation and 
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memory recall are positive. The measure was developed for use with people with 
intellectual disabilities and has demonstrated internal reliability and concurrent validity. 
 
The Emotional Quotient Inventory (EQI)(BarOn, 1997)(see Appendix 13)  
This is a self-report measure consisting of 133 items which are designed to measure an 
individual’s ability to perceive, identify and manage emotion. The items have a five 
point rating scale and can be summed to give a total score as well as subscale scores 
which are as follows:- intrapersonal, interpersonal, stress management, adaptability and 
general mood. High scores indicate people who are ‘in touch with’ their feelings and 
emotions i.e. they know what they are feeling and understand why they feel that way. 
The measure has been found to have both good reliability and validity (Dawda & Hart, 
2000). 
 
9.1 Multiple Regression:  Anger Management Group 
Table 9.0 outlines descriptive statistics for the Imaginal Provocation Test. A minus value 
for mean score indicates an increase in scores from pre to post treatment, i.e. a positive 
treatment gain score.  
 
Table 9.0 Descriptive statistics for the Imaginal Provocation Test (IPT) 
IPT Subscale Number 
completed (N) 






14 2.36 4.749 
Anger Composite 14 2.57 5.667 
Anger Regulation 14 -3.14 3.592 
Imaginal Clarity 14 2.00 0.008 
Memory Recall 14 -1.21 1.626 
Anger Reaction 14 0.21 1.805 
Italics indicate data that is NOT normally distributed 
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Tables 9.1 to 9.5 provide a summary of the results from correlations which were 
conducted to assess the contribution of cognitive factors in relation to participants’ 
treatment gain scores on the subscales of the Imaginal Provocation Test (IPT). Only 
significant results are reported and any data that was not normally distributed following 
transformation, the non-parametric equivalent test was used. 
 
Table 9.1 Summary of cognitive predictor variables significantly related to the 
Behavioural Reaction Subscale of the IPT  
Cognitive Predictor variables Pearson’s Correlation Sig for 
Behavioural Reaction Subscale 
Inattention Omission t score .004 
Inattention Omission percentile .003 
Inattention change t score  .033 
SS picture completion .027 
Correlations are significant at the 0.05 level (2-tailed). 
 
Table 9.2 Summary of cognitive predictor variables significantly related to the Anger 
Composite Subscale of the IPT  
Cognitive Predictor variables Pearson’s Correlation Sig for Anger 
Composite Subscale 
Inattention Omission t score .046 
Inattention Omission percentile .042 
Inattention Response Time percentile  .014 
Picture completion SS .035 






Table 9.3 Summary of cognitive predictor variables significantly related to the Anger 
Regulation Subscale of the IPT  
Cognitive Predictor variables Pearson’s Correlation Sig for Anger 
Regulation Subscale 
IED stages complete  .040 
IED stages complete SS .043 
IED total errors SS  .017 
Digit Symbol SS .014 
Block Design SS .010 
Symbol Search SS .025 
Correlations are significant at the 0.05 level (2-tailed). 
 
Table 9.4 Summary of cognitive predictor variables significantly related to the Memory 
Recall Subscale of the IPT  
Cognitive Predictor variables Pearson’s Correlation Sig for Memory 
Recall Subscale 
Inattention Standard Error t score .019 
Inattention Variability t score .004 
Inattention change t score .028 
Inattention change percentile .043 
Inattention Omission t score .002 
Inattention Omission percentile .005 








Table 9.5 Summary of cognitive predictor variables significantly related to the Anger 
Reaction Subscale of the IPT  
Cognitive Predictor variables Pearson’s Correlation Sig for Anger 
Reaction Subscale 
CANTAB Rapid Visual Information 
Processing SS  
.020 
Vocabulary SS .002 
Digit Symbol SS .046 
Symbol Search SS .015 
Correlations are significant at the 0.05 level (2-tailed). 
 
Due to the small sample size it was not possible to perform regression analysis on the 
above data. 
 
9.2 Novaco Anger Scale and Provocation Inventory (NAS-PI) 
Table 9.6 outlines descriptive statistics for the NAS-PI. A minus value for mean score 
indicates an increase in scores from pre to post treatment, i.e. a positive treatment gain 
score.  
Table 9.6 Descriptive statistics for the Novaco Anger Scale- Provocation Inventory 
(NAS-PI) 
NAS-PI Subscale Number 
completed (N) 




Total Score 41 -1.66 9.475 
Cognitive  41 -0.90 4.176 
Arousal 41 -0.22 3.966 
Behavioural 41 -0.54 3.861 
Anger Regulation 41 -0.2 3.523 
Provocation 
Inventory 
36 1.99 0.044 
Italics indicate data that is NOT normally distributed 
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Tables 9.7 to 9.11 provide a summary of the results from correlations which were 
conducted to assess the contribution of cognitive factors in relation to participants’ 
treatment gain scores on the subscales of the NAS-PI. Only significant results are 
reported and any data that was not normally distributed following transformation, the 
non-parametric equivalent test was used. 
 
Table 9.7 Summary of cognitive predictor variables significantly related to the Total 
Score Subscale of the NAS-PI  
Cognitive Predictor variables Pearson’s Correlation Sig for Total 
Score Subscale 
SOC mean subsequent time SS  .025 
SOC mean initial time SS .013 
Correlations are significant at the 0.05 level (2-tailed). 
 
Table 9.8 Summary of cognitive predictor variables significantly related to the 
Cognitive Subscale of the NAS-PI  
Cognitive Predictor variables Pearson’s Correlation Sig for Cognitive 
Subscale 
Similarities SS .026 
SOC mean initial time SS .047 
Correlations are significant at the 0.05 level (2-tailed). 
 
Table 9.9 Summary of cognitive predictor variables significantly related to the Arousal 
Subscale of the NAS-PI  
Cognitive Predictor variables Pearson’s Correlation Sig for Arousal 
Subscale 
Attention Deficit confidence index  .041 
SOC mean initial time SS .026 
SOC mean subsequent time SS .028 
SOC problems solved SS .008 
Faces II Recognition SS .028 
Correlations are significant at the 0.05 level (2-tailed). 
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Table 9.10 Summary of cognitive predictor variables significantly related to the Anger 
Regulation Subscale of the NAS-PI  
Cognitive Predictor variables Pearson’s Correlation Sig for Anger 
Regulation Subscale 
Vigilance Response Time t score  .035 
Correlations are significant at the 0.05 level (2-tailed). 
 
Table 9.11 Summary of cognitive predictor variables significantly related to the 
Provocation Inventory Subscale of the NAS-PI  
Cognitive Predictor variables Spearman’s Rho Correlation Sig for 
Provocation Inventory Subscale 
Inattention Standard Error t score .044 
Inattention Standard Error percentile .035 
Impulsivity percentile .042 
Attention Deficit confidence index  .034 
Verbal IQ actual difference .050 
Correlations are significant at the 0.05 level (2-tailed). 
 
 
Based on the above correlation analyses the significantly related variables were entered 
into a regression model. Tables 9.12 to 9.16 provide a summary of the results from 
multiple regression analyses which were used to assess the contribution of the predictor 
variables i.e. cognitive factors in relation to participants’ treatment gain scores on the 









Table 9.12 Summary of results from multiple regression on the Total score Subscale of 
the NAS-PI 
      




Model 1 – 
Stockings Of 
Cambridge (SOC) 
mean subsequent time 
SS 



































Table 9.12 indicates that although the predictor variables were not significant 
individually, together the model proved significant at p=.027. 
 
Table 9.13 Summary of results from multiple regression on the Cognitive Subscale of 
the NAS-PI 
      





































Table 9.13 indicates that the predictor variable Similarities SS was significant 




Table 9.14 Summary of results from multiple regression on the Arousal Subscale of the 
NAS-PI 
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Each PV was entered in the model described above  
 
Table 9.14 indicates that all three models were significant and three predictor variables 
individually were significant i.e. SOC mean sub SS (p=.038), SOC problems solved SS 









Table 9.15 Summary of results from linear regression on the Anger Regulation Subscale 
of the NAS-PI 
      































Table 9.15 indicates that the predictor variable Vigilance RT t score is predictive of 
treatment gain scores on the Anger Regulation subscale of the NAS-PI (p=.035).   
 
Table 9.16 Summary of results from multiple regression on the Provocation Inventory 
Subscale of the NAS-PI 
      
PV b SE b Adjusted 
R Square 
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Table 9.16 indicates that both models were not significant and none of the predictor 
variables individually were significant. 
 
9.3 Emotional Quotient Inventory (EQI) 
Table 9.17 outlines descriptive statistics for the EQI. A minus value for mean score 
indicates an increase in scores from pre to post treatment, i.e. a positive treatment gain 
score.  
 
Table 9.17 Descriptive statistics for the Emotional Quotient Inventory (EQI) 
EQI Subscale Number completed 
(N) 




Total Score 31 -5.23 12.465 
Intrapersonal 31 -5.45 11.50 
Interpersonal 31 -1.97 12.26 
Stress 
Management 
31 -3.90 12.81 
Adaptability 31 -6.06 15.425 
General Mood 36 1.97 0.103 
Italics indicate data that is NOT normally distributed 
 
 
Tables 9.18 to 9.21 provide a summary of the results from correlations which were 
conducted to assess the contribution of cognitive factors in relation to participants’ 
treatment gain scores on the subscales of the EQI. Only significant results are reported 
and any data that was not normally distributed following transformation, the non-





Table 9.18 Summary of cognitive predictor variables significantly related to the 
Intrapersonal Subscale of the EQI  
Cognitive Predictor variables Pearson’s Correlation Sig for 
Intrapersonal Subscale 
Inattention Response Time t score  .019 
Correlations are significant at the 0.05 level (2-tailed). 
 
Table 9.19 Summary of cognitive predictor variables significantly related to the 
Interpersonal Subscale of the EQI  
Cognitive Predictor variables Pearson’s Correlation Sig for 
Interpersonal Subscale 
Information SS .004 
Symbol Search SS .023 
Processing Speed Index .034 
Correlations are significant at the 0.05 level (2-tailed). 
 
Table 9.20 Summary of cognitive predictor variables significantly related to the 
Adaptability Subscale of the EQI  
Cognitive Predictor variables Pearson’s Correlation Sig for 
Adaptability Subscale 
Inattention Omission percentile  .029 
SOC Mean Subsequent time SS .016 
SOC problems solved SS .049 







Table 9.21 Summary of cognitive predictor variables significantly related to the Stress 
Management Subscale of the EQI  
Cognitive Predictor variables Pearson’s Correlation Sig for Stress 
Management Subscale 
SOC Mean Initial time SS .010 
Correlations are significant at the 0.05 level (2-tailed). 
 
Based on the above correlation analysis the significantly related variables were entered 
into a regression model. Tables 9.22 to 9.25 provide a summary of the results from 
multiple regression analyses which were used to assess the contribution of the predictor 
variables i.e. cognitive factors in relation to participants’ treatment gain scores on the 
various subscales of the EQI:-  
 
Table 9.22 Summary of results from linear regression on the Intrapersonal Subscale of 
the EQI 
      






























Table 9.22 indicates that the predictor variable Inattention Response Time t score is 






Table 9.23 Summary of results from multiple regression on the Interpersonal Subscale 
the EQI 
      




Model 1 – 
Information 
SS 











































Table 9.23 indicates that the predictor variable Information scaled score is significant in 
predicting treatment gain scores on the Interpersonal subscale of the EQI (p= .004). 
However, the predictor variables in model 2 are not significant either individually or 
collectively. 
 
Table 9.24 Summary of results from linear regression on the Stress Management 
Subscale of the EQI 
      































Table 9.24 indicates that the predictor variable SOC mean initial time SS is significant in 




Table 9.25 Summary of results from multiple regression on the Adaptability Subscale 
the EQI 
      
























































Table 9.25 indicates that in model 1 the predictor variable Inattention Omission 
Percentile is significant in predicting treatment gain scores on the Adaptability subscale 
of the EQI (p= .030). In model 2 the predictor variable SOC mean sub SS is significant 
individually at p=.024 and the model as a whole is significant at p=.009. 
 
 
9.4 Summary and Discussion of Findings 
The results indicate that cognitive predictor variables of memory, attention, IQ and 
executive functioning were significantly predictive of treatment gain scores in the NAS-
PI, and similarly in the EQI apart from memory. Executive functioning was again a 
frequently significant predictor variable in the EQI measure with significant results in 
the Adaptability and Stress Management subscales. However, on the Adaptability 
Subscale this relationship was negative meaning that as treatment gain scores increased 
executive functioning scores decreased. A possible explanation for this may be that 
adapting to situations and managing stress require the ability to plan and problem solve, 
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which are both executive functioning skills, resulting in this cognitive variable being 
significantly predictive.   
 
In the Total score subscale of the NAS-PI executive functioning variables were not 
significant individually, but together were predictive of treatment gain scores. However, 
in the Arousal subscale both executive functioning variables were predictive 
individually and collectively. This may be a result of the connection between executive 
functioning and emotion regulation in predicting treatment outcome (Fishbein et al., 
2006).  
 
Results from the above analyses are reviewed in the discussion section in relation to the 
research hypotheses and the research questions. The results are also considered in 






















The present study used an exploratory quantitative approach to investigate if cognitive 
impairment was related to treatment responsivity in mentally disordered offenders. The 
results concerning the demographic and clinical profiles of the participants are reviewed, 
and the main findings are discussed in relation to previous research and the research 
hypotheses and questions. Following this the limitations of the current study and 
suitability of the methodology are explored. Finally the clinical implications of this 
research are discussed along with the potential for future research in this area.  
10.2. Demographic and clinical profile of participants   
Participants in the study primarily had a diagnosis of schizophrenia or other psychotic 
disorder (78%). Almost a quarter of the sample (23%) had a diagnosis of personality 
disorder, which is a significant proportion, and often in conjunction with psychosis. 
When such co-morbid difficulties, combined with violent offending behaviour and 
potential substance misuse exist, treatment responsivity is further complicated (Preston, 
2000). The age range of 20-67 years allowed a wide range of the population to 
participate in the study, and therefore age could be considered a potential predictor 
variable in relation to outcome scores. As such any potential variation in performance 
due to age could be ascertained. Previous research by Fishbein et al., (2006) in this area 
excluded participants over the age of 49 meaning a more restricted sample, and therefore 
it may be viewed as a strength of this study that a wider range of participants were 
included. Likewise participants were not excluded on the basis of a low IQ as in the 
Fishbein et al., (2006) study, meaning that these results reflect the full range of 
capabilities of an MDO sample. Rather than exclude participants on the basis of low IQ, 
group programmes in The hospital in this study are adapted to meet their needs and 
participants are supplied with extra 1-1 support should they require it. However, as the 
previous research discussed has been conducted on a prison population, the demographic 
and clinical profile of participants in this study appears to be characteristic of an MDO 
population in Scotland. 
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10.3 Summary and interpretation of the research findings  
  10.31 The role of memory in treatment gain 
Research hypothesis 1: There will be a significant positive association between memory 
functioning as measured by the Wechsler Memory Scale Third Edition (WMS-III) 
(Wechsler, 1997), and treatment gain as measured by pre and post treatment scores. 
 
Several significant relationships were found between memory predictor variables and 
outcome scores on the Drug and Alcohol Knowledge Questionnaires, the CRI and SPSI 
(used in the Social Problem Solving Group) and the NAS-PI (used in the Anger 
Management Group). The results indicate that memory is an important predictor variable 
for treatment outcome scores as measured by several reliable and valid outcome 
measures. However, in comparison to the results on the other cognitive domains 
assessed in this study and their ability to predict treatment response, memory appears to 
play a reduced role than what might be expected. Previous research has found verbal 
memory specifically to be predictive of functional outcome in schizophrenia (Green et 
al., 2004).    
 
Nonetheless, collectively the results show that memory functioning is associated with 
participants’ treatment gain scores as measured by pre and post treatment scores. The 
research hypothesis can therefore be accepted, as memory functioning was associated 
with treatment gain.  
 
10.32 The role of attention in treatment gain 
 
Research hypothesis 2: There will be a significant positive association between attention 
functioning as measured by the Test of Variables of Attention (TVA) (Greenberg & 
Waldman, 1993), and treatment gain as measured by pre and post treatment scores. 
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Attention proved to be a significant predictor variable in treatment gain scores on the 
Drug Knowledge questionnaire, the DTCQ, the Understanding of Medication 
questionnaire (used in the CWMI group), the CRI and SPSI, and the NAS-PI and EQI. 
Therefore attention was a significant predictor variable across all the groups and on 
several outcome measures. A possible explanation for the increased role of attention in 
comparison to memory assessed in Hypothesis one, may be that in order to recall 
information it must first be properly encoded which requires attending to the 
information. As such, if a participant has difficulty concentrating and paying attention to 
information presented in a group, and sustaining attention for the duration of a session 
this may be more predictive of their performance in treatment rather than memory ability 
(Medalia & Choi, 2009). The results appear to concur with previous research which 
found cognitive impairments in areas such as attention, predicted ability to meet 
functional goals in people with schizophrenia (Green et al., 2004).  
 
In sum, the results show that attention is associated with participants’ treatment gain 
scores as measured by pre and post treatment scores. The research hypothesis can 
therefore be accepted, as attention was associated with treatment gain.  
 
10.33 The role of executive functioning in treatment gain 
 
Research hypothesis 3: There will be a significant positive association between 
executive functioning as measured by the Cambridge Automated Neuropsychological 
Test Automated Battery (CANTAB) (Robbins & Sahakian, 1988), and the Speed and 
Capacity of Language Processing Test (SCOLP) (Baddeley, Emslie & Nimmo-Smith, 
1992), and treatment gain as measured by pre and post treatment scores. 
 
Executive functioning variables proved to be significant in predicting treatment gain 
scores on numerous measures across the Drug and Alcohol Saying No Group, Social 
Problem Solving Group and Anger Management group. However this did not appear to 
be the case in the Drug and Alcohol Education Group and CWMI group. It may be that 
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these two psycho-educational groups do not require the same planning and problem 
solving skills as a more CBT based course such as Anger Management. An alternative 
explanation may be that these groups used measures which have not been tested for 
reliability and validity, which may have impacted on the findings.   
 
Nonetheless, the results concur with previous research highlighting the role of executive 
functioning in predicting treatment response from a CBT programme (Fishbein et al., 
2006). Overall the results show that executive functioning is associated with 
participants’ treatment gain scores as measured by pre and post treatment scores. The 
research hypothesis can therefore be accepted, as executive functioning was associated 
with treatment gain. 
  
10.34 The role of IQ in treatment gain 
 
Research hypothesis 4: There will be a significant positive association between IQ as 
measured by the Wechsler Adult Intelligence Scale Third Edition (WAIS-III) (Wechsler, 
1997), and treatment gain as measured by pre and post treatment scores. 
 
IQ predictor variables were significantly predictive in the D&A Education group, the 
CWMI group, and the Anger Management group. However, as noted previously in the 
D&A Education group, IQ was predictive as part of a regression model and not 
individually. In the CWMI and Anger groups IQ variables were significant individually 
in predicting treatment gain scores. In the CWMI group the IQ variable Picture 
Completion SS (part of Performance IQ) was predictive for the Understanding of 
Medication Questionnaire. This may reflect the need for more global cognitive ability to 
understand information, as opposed to specific planning or problem-solving skills 
reflected by executive functioning. Similarly in the EQI measure, the IQ variable 
Information SS (part of Verbal IQ) was predictive of treatment gain scores on the 
Interpersonal subscale. A possible explanation for this may be that general intelligence is 
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more predictive of interpersonal functioning rather than specific cognitive measures 
such as executive functioning. This would concur with previous research, which found 
that general IQ was more predictive of functional outcome in patients with 
schizophrenia, than more specific measures of memory or executive functioning (Leeson 
et al., 2009). 
 
To summarise, the results show that IQ is associated with participants’ treatment gain 
scores as measured by pre and post treatment scores. The research hypothesis can 
therefore be accepted, as IQ was associated with treatment gain.  
 
 10.4 Exploratory Research Questions 
The following exploratory questions were also considered in relation to the research 
findings:  
 
i) Are some forms of cognitive impairment more predictive than others in determining 
response to treatment? 
 
It would appear from the results that attention predictor variables were the most 
frequently significant variables in predicting response to treatment. Measures of 
attention were predictive across all the groups whether psycho-educational or CBT 
based. This may be because, as discussed previously, deficits in attention may make it 
difficult for an individual to benefit from treatment, as they are unable to process and 
retain information, or maintain attention during sessions. However, all the cognitive 
predictor variables proved significant in predicting treatment outcome scores, and any 
variation in their predictive ability may be due to differences between the groups and the 
outcome measures used. 
 
ii) Is there a difference between the type of group treatment and the consequent impact 
of cognitive variables on a patient’s response? 
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The results indicate that treatment gain scores in all the groups were associated with 
cognitive impairment scores in at least one domain. Furthermore, treatment gain scores 
in the NAS-PI measure in the Anger Management group were predicted by at least one 
predictor variable from the domains of attention, IQ, memory and executive functioning. 
This is a CBT based group and in comparison to the two psycho-educational groups 
(D&A Education and CWMI), may require higher order cognitive skills such as 
executive functioning. This would appear to concur with the results from this study 
which indicate that executive functioning was not predictive of treatment gain scores in 
the two psycho-educational groups. These results therefore suggest that the CBT based 
groups (D&A Saying No, Social Problem Solving and Anger Management) require 
higher order cognitive skills such as executive functioning, whereas the psycho-
educational groups do not.   
 
iii) Is there a difference between schizophrenia or other diagnoses in regards to cognitive 
impairment and response to treatment? 
 
The majority of participants in this study had a diagnosis of schizophrenia or other 
psychotic disorder (78%). As such comparing participants on the basis of diagnosis was 
not considered relevant under these circumstances, due to unequal group sizes making 
statistical analysis problematic. 
 
iv) Does age have an impact on cognitive impairment and response to treatment when 
considered as a predictive factor? 
Following correlational analyses no significant relationships were found between age 
and cognitive impairment variables, precluding regression analysis. The fact that age 
was not found to be a significant predictor variable for cognitive impairment concurs 
with previous research, stating that cognitive impairment is relatively stable from the 
onset of schizophrenia to approximately 65 years of age in the majority of patients 
(Green, 2006).  
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10.41 Key Findings 
To summarise, the study findings indicate that cognitive impairment does impact on 
treatment responsivity in mentally disordered offenders. This is evidenced firstly in the 
domain of memory as results revealed higher memory scores were associated with 
higher treatment gain scores. Conversely those with poorer memory functioning had 
reduced treatment gain scores. These results would appear to concur with research cited 
previously which indicated deficits in working memory in rats with a damaged 
hippocampus which mimicked the symptoms of schizophrenia (Lipska et al., 2004).  
 
In regards to attention, the results revealed that greater inattention scores resulted in 
decreased treatment gain scores i.e. the more impulsive and unable to concentrate an 
individual is the less they benefitted from treatment.  As such, this study lends further 
support to the evidence base that cognitive abilities such as sustained auditory attention 
are necessary in order to benefit from treatment (Kurtz et al., 2008). 
 
Executive functioning was also significantly correlated with treatment gain scores 
meaning that the more difficulties an individual had with planning and problem-solving, 
the less they benefitted from treatment. These findings concur with those cited earlier 
from a prison population where executive functioning predicted response to CBT 
treatment (Fishbein et al., 2006).    
 
Finally in the domain of IQ the findings from this study indicate that the higher an 
individual’s IQ is the more likely they are to receive greater benefit from treatment. This 
evidence supports that discussed previously which demonstrated the importance of 
targeting cognitive impairment as a treatment intervention, and following cognitive 
remediation patients display improved cognitive skills (Medalia & Choi, 2009). 
Enhancing an individual’s cognitive abilities allows them to gain maximum benefit from 
treatment, and the results of this study support the need to improve IQ in schizophrenia 
to optimise treatment gain. The findings therefore overall lend further support to the 
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existence of cognitive impairment in schizophrenia, and specifically in a population of 
mentally disordered offenders. 
 
10.5 Critical Evaluation of the study 
 
This research study will now be critically evaluated by addressing the strengths and 
weaknesses of the methodology. Factors such as sample size, the measures used, 
differences in the groups, use of existing data, and the statistical analysis are reviewed in 
the following sections.  
 
10.51 Statistical analysis 
Using multiple regression requires the data to meet several assumptions such as 
sufficient numbers (Dancey & Reidy, 2004). Although this assumption was not violated, 
it was not possible to conduct regression analysis with some of the smaller groups due to 
insufficient numbers. Small sample size also results in the power of any findings being 
weakened which is a consideration given the largest group in the study consisted of 58 
participants. The results did reveal several significant findings, however greater numbers 
in each group would produce more reliable results, and greater confidence in the ability 
to extrapolate the findings to a wider population. Furthermore, a larger sample would 
have allowed the use of statistical methods of regression which may have been more 
sophisticated and sensitive to change (Brace et al., 2006). Nonetheless, this study 
incorporated data from 114 mentally disordered offenders, a population that is under 
researched and from which it is difficult to recruit participants (McGuire, 2000). The 
data was also separated into groups based on the psychological intervention completed 
to allow specific examination of performance in each group, rather than a more general 
overview of treatment gain. 
 
Due to the exploratory nature of this study numerous variables were assessed using 
correlational analysis. This does not allow the direction of causality to be measured 
meaning that interpretations of these relationships must be made with caution (Dancey 
& Reidy, 2004).  
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The study involved the use of pre-existing data some of which was routinely collected 
for service evaluation purposes. However, if a participant did not complete treatment or 
was transferred prior to completion of treatment, post group psychometrics were not 
conducted. It was therefore not possible to establish treatment gain scores meaning that 
the sample size was reduced in each group. This also resulted in a lack of data on people 
who did not complete treatment, and comparisons between completers/non completers 
could therefore not be made. 
 
10.52 Group Therapy Factors 
In relation to the group treatments a relevant issue may be the order in which 
participants complete group treatments. As part of the treatment process patients in The 
hospital in this study routinely complete psycho-educational groups first such as the 
CWMI and Drug and Alcohol Education groups, before moving on to longer more CBT 
based intervention such as Anger Management. As such these groups may therefore be 
the first psychological treatment patients have been exposed to. This also means that 
participants in groups such as Anger Management may well have already completed 
groups such as CWMI and Drug and Alcohol Education. These patients have therefore 
been exposed to more psychological therapy and as a result may be more 
psychologically minded and responsive to treatment. This may lead to higher treatment 
gain scores compared with participants who have had their first experience of 
psychological therapy. 
 
A further issue which may have impacted on the results is the duration of the group 
treatment. The Drug and Alcohol Education group runs for ten one hour sessions in 
comparison to the Anger Management group which consists of 20 sessions lasting 
approximately 2.5 hours. This is a significant difference in duration of treatment and 
may impact on the treatment gain scores achieved, as longer groups may require more 
sustained attention and memory from session to session. Due to the difference in the 
groups on factors such as duration of treatment and psycho-education versus CBT, 
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statistical comparisons between them were not conducted as this would be an unfair 
comparison. 
 
The skill mix of staff in the groups, level of training and experience may have impacted 
on treatment outcome. The Psychological Therapies Service groups are run by various 
members of staff using a multi-disciplinary approach. However, nursing staff who 
volunteer to become involved in psychological therapy are seconded to the service either 
part time or full time. As such, some of the staff may not have specific qualifications in 
psychological therapies such as CBT, and may not have the same experience as other 
staff. Similarly groups involve members of staff at various stages of training from 
assistant to consultant level, and this variation may impact on treatment delivery. 
 
As stated previously patients normally complete psycho-educational groups first before 
moving on to more complex treatments. These patients are generally at the beginning of 
their admission and although their mental health may have stabilised, they may still be 
quite unwell in comparison to patients who have been stabilised on medication for many 
years. Participants may also have completed more than one psychological group, and 
may have been engaged in more than one group at a time. However, participation in 
more than one therapy at a time is generally avoided to ensure patients do not become 
over-loaded. 
 
10.53 Psychometric Measures 
The various psychological groups assessed in this study use different psychometrics to 
assess the effectiveness of treatment. As stated in section 3.4.1 some of these measures 
were developed by the hospital in this study, and have therefore not been assessed for 
reliability and validity. There is also the issue of groups using different measures, some 
of which may be more sensitive to change than others and thereby impact on the results. 
Notwithstanding these limitations, the groups used several reliable and valid outcome 
measures, and more than one measure for each group.  
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An issue discussed in section 1.7 relates to how to measure treatment change. In this 
study treatment change was determined by the difference between pre and post treatment 
scores. However, this does not take into account clinical impressions on performance in 
treatment which may be different to any apparent gain on outcome measures. The 
outcome measures are also self-report meaning that it is possible for an individual to 
complete them in such a way as to make their performance look favourable. This may be 
particularly relevant in forensic settings were patients wish to “get out” and therefore 
modify their responses to demonstrate positive findings. Offenders often engage in 
treatment due to pressure from external sources such as family or friends or in an 
attempt to reduce their sentence (Kennedy, 2000). The outcome data in this study was 
collected as part of routine service evaluation and was therefore relevant to the patient’s 
care. In comparison, if the treatment outcome data had been collected specifically for 
research purposes, and had no impact on participants treatment they may have been 
more likely to answer freely. The cognitive data which was collected as part of a 
neuropsychological research study may therefore be more reliable than the treatment 
outcome data.  
 
The use of self-report measures may also be problematic due to the cognitive limitations 
of participants. If they have poor literacy skills and a low IQ they may struggle to 
understand questionnaires unless they are explained. This issue has been highlighted in 
patients with poor concentration and fatigue where self-report measures have been 
suggested to have limited usefulness (Faravelli et al., 1986).  
 
10.54 Cognitive data 
A potential weakness in the research methodology was that not all participants had their 
neuropsychological assessment conducted prior to commencement of treatment. As the 
research involved the use of existing neuropsychological data which was matched to 
service evaluation data (treatment gain and adherence scores), some participants may 
have engaged in treatment before or after their neuropsychological assessment. In 
previous research cognitive functioning has been measured prior to treatment in order to 
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gain a true reflection of the impact of this on treatment outcome (Fishbein et al., 2006). 
Conducting neuropsychological assessment after treatment may alter the findings as 
treatment may impact on an individual’s ability level, as they may have improved 
attention and memory having been required to attend to information presented and 
remember this between sessions. Therefore, future prospective research should aim to 
ensure neuropsychological assessment is conducted prior to treatment.  
 
There was also variation in the time between neuropsychological assessment and 
treatment, with some participants having a longer or shorter time period between 
assessment and treatment. However, in order to assess the relevance of this issue a 
sample of participants was selected who had completed treatment and 
neuropsychological assessment within a two year time period. The correlation and 
multiple regression analyses was re-run on this group, and no significant differences 
were found between this group and those included outwith the two year time frame. 
Therefore it would appear that the issue of time between neuropsychological assessment 
and treatment did not appear significant in this study. Previous research indicates that 
cognitive impairment is stable in schizophrenia, and there is no significant difference in 
people with first episode psychosis and patients with chronic schizophrenia (Hutton et 
al., 2002). The fact that time between neuropsychological assessment and treatment in 
this study had no significant impact on the results, appears to concur with the evidence 
supporting the stability of cognitive impairment in schizophrenia.  
 
The battery of neuropsychological assessments conducted was thorough allowing a 
broad range of cognitive domains to be measured. This is in comparison to the potential 
use of a more general measure of functioning such as the WAIS alone, or screening 
measures such as the Addenbrooke’s Cognitive Examination –Revised (ACE-





10.55 Use of existing data 
Using existing data within the hospital was beneficial in that no further recruitment was 
required. This is important as the patients within the hospital are frequently being asked 
to participate in research and are arguably over researched. Making use of existing data 
can also be viewed as part of service evaluation and therefore meets the requirements of 
clinical governance/audit, as well as being cost effective. However, it would be 
preferable for future research to utilise a prospective study design in order that 
predictions regarding future behaviour can be made. Nonetheless, as this study involved 
assessing the impact of cognitive impairment on treatment gain and adherence a 
retrospective design was appropriate.  
 
The exploratory nature of this study may mean that not all variables were explored that 
could have been relevant. However, it may be viewed as a baseline from which future 
research exploring cognitive impairment and treatment responsivity can be guided. 
Although weaknesses of the research have been highlighted the results indicate the role 
of cognitive impairment in predicting treatment gain and adherence in mentally 
disordered offenders. The clinical implications of this are now discussed. 
 
10.6 Clinical Implications 
The results from this study reinforce the relevance of viewing cognitive impairment as a 
specific treatment target in schizophrenia, and recognition of these deficits as a core 
symptom of schizophrenia. Previous research states that cognitive skills programmes are 
more effective with offenders of average to high-average intelligence, than those with 
below average intelligence (Fabiano, Porporino, & Robinson, 1991). This being the case 
there would appear to be a strong argument for addressing cognitive impairment and 
attempting to improve deficits in cognitive functioning. The results indicate that 
cognitive impairment is significantly predictive of response to treatment. This finding in 
a population of MDO’s, concurs with previous research findings in an offender and 
outpatient setting (Fishbein et al., 2006; Leeson et al., 2009). It has been stated that 
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interventions for MDO’s should be based on knowledge of more researched populations 
such as offenders, and the results from this study appear to support this argument 
(McGuire, 2000).  
Given that treatment responsivity has a subsequent impact on recidivism these results 
lend support to the need to address both cognitive impairment and treatment 
responsivity. Risk management is an integral part of rehabilitating mentally disordered 
offenders, and incorporating cognitive impairment and its’ impact on treatment 
responsivity may significantly enhance effective risk management. An individual’s 
response to treatment is crucially important in order to reduce the probability of 
reoffending, and successfully rehabilitate offenders (Kennedy, 2000). 
The findings from this study support the use of pre-group screening to determine which 
MDO’s are most likely to benefit from treatment based on their level of cognitive 
impairment. By identifying what specific deficits an individual has, treatment can then 
be modified accordingly in order that maximum benefit may be achieved. Knowledge 
and awareness of the impact of an individual’s cognitive deficits on their functioning, 
will allow group and/or individual treatment to be tailored to meet these demands. Given 
that treatment should be driven by a formulation of each individual’s needs, this 
approach fits with the new clinical model proposed by the hospital in this study. A 
further benefit may result if fewer individuals are required to repeat treatment, or there is 
a reduction in the number who undergo treatment with limited or no significant 
improvement upon completion.  
 
10.7 Future Research 
In relation to the study limitations highlighted previously there are several potential 
options for future research that may minimise these weaknesses. A cognitive 
remediation service is due to be implemented within the hospital and these findings add 
further justification for the potential benefits of such an intervention. Research indicates 
that people with schizophrenia can benefit from cognitive remediation (Medalia & Choi, 
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2009), and as part of service evaluation the effectiveness of this intervention could be 
assessed in MDO’s.  
 
If replicating this study, as stated previously conducting neuropsychological assessment 
prior to treatment would be preferable. Using measures such as the Treatment 
Responsivity and Treatment Gain Scales (Serin, 1998) would allow a more specific 
measure of treatment responsivity to be established. These measures were developed to 
measure performance in CBT and if looking at several group treatments, they could be 
used across all groups to allow comparisons to be made. In order to ensure statistical 
accuracy the study would require repetition on a larger sample, particularly if using 
statistical methods of regression analysis. 
 
10.71 Measuring Treatment Outcome 
The use of valid, reliable psychometrics to assess outcome scores should always be used 
where possible in research. Although the majority of measures used in this study were 
valid and reliable, this should be ensured in future research. It may also be helpful to 
gain a qualitative perspective on participants’ thoughts and feelings regarding treatment. 
This may reveal a more detailed analysis of factors affecting treatment responsivity. 
 
10.72 Comparing Group Treatments 
Although some comparisons were made between the groups in this study in relation to 
the predictive ability of cognitive impairment, the differences between the groups made 
this problematic. Future research should compare equal groups in terms of variables 
identified such as size of group, duration of treatment, type of group (Psycho-
educational or CBT), skill mix of staff and use of similar outcome measures. This would 
allow a much fairer comparison to be made without other confounding variables 
potentially impacting on the results.  It may then be possible to determine accurately if 
differences exist between CBT and psycho-educational groups, or if variables such as 
duration of treatment have an impact on results.   
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10.8 Summary and conclusions  
Although weaknesses in this study were identified, the results highlight that cognitive 
impairment is associated with response to treatment in MDO’s. This is important when 
considering what treatment to offer an individual, and how this may be maximised by 
initially identifying cognitive deficits for treatment. Furthermore, the results indicate that 
all aspects of cognition i.e. executive functioning, IQ, memory and attention are related 
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This looks like an interesting study and luckily doesn’t require recruitment or (additional) IRAS ethics approval within the 
available time frame.  Presuming that data sets are complete, I do not see any issues with proceeding with the study. 
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1. The power analysis is confusing.  But I don’t see the point of doing one at all if you are using a pre-existing data set 
and don’t need to recruit. 
2. Do you need additional approval to access this data e.g. Caldicott guardian approval?  Is the project having any other 
ethical review e.g. have all the relevant School of Health forms been completed? 
3. I think you could explain in greater detail how the results could allow more rigorous risk assessment and management 
of offenders (p2, end of first paragraph).   
4. I am assuming that the cognitive tests and initial relevant measures were completed pre treatment- I’m sure they are 
but I don’t think this is stated on the form! 
5. When you write up in your thesis you don’t need to replicate the inclusion criteria within the exclusion (both consent 
issues) 
6. Are there actually 5 predictors in the regression?  Looked like executive functioning had two scores. 
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Pre/Post Drug Knowledge Questionnaire 
 
True    False 
 
1. Cannabis is a class A drug         ⁯       ⁯ 
 
2. You can be given sentences of up to life imprisonment and fined unlimited  
sums of money for dealing in Class A drugs.          ⁯        ⁯ 
 
3.  Ecstasy use can make you so overactive that your body dehydrates and  
  overheats so much that you can die as a consequence                   ⁯        ⁯ 
 
4. Inhaling solvents is not illegal so it is considered safe                   ⁯        ⁯ 
 
5. LSD can look like a piece of paper, the size of a stamp      ⁯        ⁯ 
 
6. Magic Mushrooms are legally classified as Class C because they 
are relatively harmless           ⁯        ⁯ 
 
7. The effects of amphetamine use can last for around 1 or 2 hours.      ⁯        ⁯ 
 
8. Driving while under the influence of any stimulants help reaction times and  
therefore makes you a safer driver            ⁯        ⁯ 
 
9. Cocaine is thought not to be a psychologically addictive substance     ⁯        ⁯ 
 
10. Illegal drugs are responsible for a lot of crime in society      ⁯        ⁯  
 
11. ‘Poppers’ cause you blood pressure to increase, your heart to slow down 
 and the effects last for approximately 2 hours       ⁯        ⁯ 
 
12. You will know if you have some form of Hepatitis because your skin will  
become yellow                   ⁯        ⁯ 
 
13.  Hepatitis B & C is found in blood, saliva and the sexual fluids of both 
  men and women            ⁯        ⁯ 
 
14. Only homosexuals and injecting drug users get HIV       ⁯        ⁯ 
 
15. There are currently 50 million people infected with HIV worldwide         ⁯        ⁯ 
 
16. Drugs that can be bought over the counter without a prescription are  







17. A person can be charged with supplying drugs if they allow friends to use  
illicit substances in their home, even if that individual is not using them  
himself.             ⁯ ⁯ 
 
18. Taking more than one drug at the same time has no potential negative  
consequences            ⁯       ⁯
  
19. The beneficial effects of Benzodiazepine’s, such as Vallium, can be lessened in  
as little as two weeks of daily use          ⁯ ⁯ 
 
20. Taking illicit drugs can lower benificial effects of prescribed medication and  
















21. Substance abuse can lead people to be violent and uncontrolled in their  
behaviours            ⁯       ⁯
              
22. Illicit drugs use can lead or trigger a relapse in long term mental  
             health problems such as depression/anxiety/schizophrenia.          ⁯ ⁯ 
 
23. There have been side effects such as confusion, sleep disorder, paranoia, 
depression and hallucinations reported with the use of ananbolic steriods.     ⁯ ⁯ 
 
       24.  Withdrawal from Heroin use is often life threatening         ⁯ ⁯ 
 
25. Whether opiate users inject or not they suffer from higher incidences of  
lung disease            ⁯       ⁯






























































































































Forensic Assessment of Knowledge Tool (F.A.K.T) 
 
We would like you to complete this short questionnaire, to find out what you know 
about mental illness. 
If you need any help to fill this in, or more information, please ask. 
 
Name:                    Date:   
 
  
Pre:                 Post:                
 
 
Gender: Male :        Female: 
 
Age group: 17 but less than 25 
     25 but less than 35 
     35 but less than 45 
     45 but less than 55 
     55 but less than 65 
 
Part one: Foundation Knowledge Of Mental Illness 
 
1) What do you understand the term mental illness to mean and what 























4) What, in you opinion, are some of the causes of mental illness’ such as 








5) a) Symptoms’ of a psychotic illness are often divided into two 
categories, Positive Symptoms’ & Negative Symptoms’. What do you think 




b) Please list some of the positive and negative symptoms’ of a 







6) People who suffer from a psychotic illness can also sometimes suffer 











7) People who suffer from a psychotic illness can also sometimes suffer 







8) People who suffer from a psychotic illness can also sometimes 
experience symptoms from a previous trauma or Post Traumatic Stress 
Disorder (PTSD).  Can you list any of the symptoms of PTSD? 
 
 
F.A.K.T. Part 2: The Legal System 
 




10) a) Are you a restricted or non- restricted patient? 
 
 













12) a) What body hears any appeals that are made? 
  
 




13) Please tick the box that shows what form you are on for your 
medication. 
 




Do not know 
 
14) What is the difference between this T2 and T3 form? 
 
 
15) If you were to receive medical treatment, for example for a physical 
complaint, who would be required to give consent? 
 
 
16) If you wanted to look at your care plan or treatment plan, who would 
you need to ask to be able to do this? 
 
 
17) If you wanted to look at your case notes, who would have to give 




18) a) Who is your named person? 
 
 
      b) What is the purpose of having a named person? 
 
 




F.A.K.T. Part 3: Coping Skills & Recovery 
 










21) Please tick the box that shows how important medication is in the 
treatment of mental illness  
 
 Very     Quite      Of little  Unimportant 











22) Please list some of the possible reasons why someone with a 










23) When people develop problems with their mental health, there can be 
some indicators that things are not going well and may be heading for a 
relapse. These indicators are often called ‘early warning signs’ Can you 
think of any commonly reported ‘early warning signs’? (Thinking back 







24) Please tick the box that shows how important carers are in helping you 
through your illness 
 
 Very     Quite      Of little  Unimportant 












26) If you or a member of your family noticed you were showing ‘early 
warning signs’, what could you do to prevent yourself from becoming 






27) Please list some of the types of support that are available for people 
who suffer from a mental illness (include both supports that are available 








28) Please list some other coping skills you could use, that are likely to be 









































Understanding of Medication Questionnaire (MacPherson) 
Name:                                         Date:  
Please circle which assessment period this applies to:  Pre :  Post  
I would like to ask you some questions about how much you know about the antipsychotic medication you 
are taking. If you are unsure of any questions, please feel free to ask. 
1) What is the name of your medication Score  





2   
 
2) What is the dose of your medication 
 
Score  

























4) How frequently do patients taking antipsychotics need to be reviewed 
by their doctors 
 
Score  











5) How does antipsychotic medication help patients 
(a) General problem area (feel better/helps sleep/nerves) 
Prompt: what problems does it help 
(b) Symptom relief (hallucinations, delusions) 
Prompt: what problems does it help reduce 
(c) Diagnostic (schizophrenia, manic depression) 
Prompt: what condition does it treat 
 
 
Score       
Prompt    
Score       
Prompt     
Score       
Prompt     






























6) Do you know the effects of stopping to take antipsychotic medication 
as shown by research 
 
Score  











7) Do you know of any side-effects of antipsychotic medication 





















0 = no knowledge 
1 = aware of side – effects, unable to describe; 
2 = knows one side-effect; 
3 = two or more side effects; 
4 = knows three or more side effects, good account 
      
 
8) Do you know of any special precautions patients are supposed to follow 
when taking this medication (alcohol/driving/machinery/sunlight/other 
drugs) 






























0 = no knowledge 
1 = aware of ‘problems’ unable to describe; 
2 = aware of one specific precaution, minimal details; 
3 = good account of two or more precautions 
      
 
9) Understanding of tardive dyskinesia 
(a) Have you heard of tardive dyskinesia? Can you describe it 
Prompt: has anyone ever mentioned a side effect of abnormal movements 
 
(b) When does tardive dyskinesia occur 
Prompt: how long after the treatment was started does it usually occur 
 
(c) What problems does tardive dyskinesia cause to patient with it  
Prompt: can the abnormal movements make people feel bad in any way 
 
(d) How is tardive dyskinesia treated 
Prompt: can it always be treated 
      
(e) How can tardive dyskinesia be prevented 






















































































10) Do you understand why antipsychotic medication is used despite the 
risk of side-effects 
Prompt: do you  understand that the benefits of medication may outweigh 























0 = no understanding 
1 = partial understanding 
2 = full understanding 
 
Prompt and error scoring 
0 = absent 
1 = present 
 
Total scores 
Total knowledge score = /35 
Total prompt score =  /11 
Total error score = /7 
















































































































People differ in the ways they act and think in difference situations. Below are a list of statements which 
measure some of the ways in which you act and think. Do not spend too much time on any statement but 
decide how much the statement applies to you. Please answer quickly and honestly by circling the number. 
 
1 = Rarely/Never applies to me 
2 = Occasionally applies to me 
3 = Often applies to me 
4 = Almost always or always applies to me 
 
  Rarely/ 
Never 
Occasionally Often Almost 
Always/ 
Always 
1 I plan tasks carefully 1 2 3 4 
2 I do things without thinking 1 2 3 4 
3 I am easy going 1 2 3 4 
4 I have thoughts that race through my mind 1 2 3 4 
5 I plan trips well ahead of time 1 2 3 4 
6 I am self-controlled 1 2 3 4 
7 I find it easy to concentrate 1 2 3 4 
8 I save regularly 1 2 3 4 
9 I find it hard to sit still for long periods of time 1 2 3 4 
10 I am a careful thinker 1 2 3 4 
11 I put effort into ensuring that I will have money to 
pay for my needs 
1 2 3 4 
12 I say things without thinking 1 2 3 4 
13 I like to think about complex problems 1 2 3 4 
14 I do not stick to jobs for long periods of time 1 2 3 4 
15 I act on “impulse” 1 2 3 4 
16 I find it boring to think about something for too long 1 2 3 4 
17 I have regular/dental check ups 1 2 3 4 
18 I act on the spur of the moment 1 2 3 4 
19 I can keep my mind on one thing for a long time 1 2 3 4 
20 I move frequently or I do not like to live in any place 
for a long time 
1 2 3 4 
21 I buy things on impulse 1 2 3 4 
22 I finish what I start 1 2 3 4 
23 I walk and move fast 1 2 3 4 
24 I solve problems by trying something out and seeing 
if it will work 
1 2 3 4 
25 I spend more than I bring in 1 2 3 4 
26 I talk fast 1 2 3 4 
27 I have irrelevant thoughts when thinking 1 2 3 4 
28 I am more interested in the present than the future 1 2 3 4 
29 I am restless about the future 1 2 3 4 




































IMAGINAL PROVOCATION TEST (IPT) 
Name ……………………………………………  Group …………………..     Date …………………… 
SCENE A 
The nurse-in-charge accuses you of causing trouble in the ward. You tell him that you were not involved. He doesn’t 
believe you. He says that you will lose your facility time and grounds access until there is a clinical team discussion. 
You try to put your point across but you are told to leave the office. 
 
1. How angry does this make you feel? 
  
Not at all A little Fairly Very 
1 2 3 4 
 
If this happened to you: 
 
2. You would swear or shout. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
3. You would want to hit the person. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
4. You would stay calm and cool. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
5. You would want to smash or kick something. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
6. You would want to tell the person off and start an argument. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
7. You would try to understand why the person did this and not get angry about it. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
8. How easy was it for you to imagine (see yourself) in this situation? 
  
Very difficult Difficult Easy Very easy 
1 2 3 4 
 
9. How easy was it for you to keep a clear picture of this situation in your head? 
  
Very difficult Difficult Easy Very easy 
1 2 3 4 
  
10. Remind me of what happened in this situation. 
(Underline each element that the patient is able to recall without prompting.) 
 
The nurse-in-charge accuses you of causing trouble in the ward/ You tell him that you were not involved/ He doesn’t 
believe you / He says that you will lose your facility time and grounds access/ until there is a clinical team discussion/ 
You try to put your point across but you are told to leave the office.  Score =  
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IMAGINAL PROVOCATION TEST (IPT) 
Name ……………………………………………  Group …………………..     Date …………………… 
SCENE B 
You return to the ward and realise that your room has been searched, without your permission. It has been left untidy.  
You complain about this to staff. You’re told that your permission is not technically required.  You are left to tidy up 
the mess. 
1. How angry does this make you feel? 
  
Not at all A little Fairly Very 
1 2 3 4 
 
If this happened to you: 
 
2. You would swear or shout. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
3. You would want to hit the person. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
4. You would stay calm and cool. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
5. You would want to smash or kick something. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
6. You would want to tell the person off and start an argument. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
7. You would try to understand why the person did this and not get angry about it. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
8. How easy was it for you to imagine (see yourself) in this situation? 
  
Very difficult Difficult Easy Very easy 
1 2 3 4 
 
9. How easy was it for you to keep a clear picture of this situation in your head? 
  
Very difficult Difficult Easy Very easy 
1 2 3 4 
  
10. Remind me of what happened in this situation. 
(Underline each element that the patient is able to recall without prompting.) 
 
You return to the ward and realise that your room has been searched/ without your permission/ It has been left untidy/ 
You complain about this to staff / You’re told that your permission is not technically required / You are left to tidy up 
the mess.   
Score =  
 187 
 
IMAGINAL PROVOCATION TEST (IPT) 
Name ……………………………………………  Group …………………..     Date …………………… 
SCENE C 
It’s 7.30am and you have had a poor sleep. A nurse wakens you and abruptly says it’s time to get up and puts your 
light on.  He tells you to make your bed and have a shower. You’re still lying in bed when another member of staff 
comes by and insists that you get up for a shower straight away. 
1. How angry does this make you feel? 
  
Not at all A little Fairly Very 
1 2 3 4 
 
If this happened to you: 
 
2. You would swear or shout. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
3. You would want to hit the person. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
4. You would stay calm and cool. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
5. You would want to smash or kick something. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
6. You would want to tell the person off and start an argument. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
7. You would try to understand why the person did this and not get angry about it. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
8. How easy was it for you to imagine (see yourself) in this situation? 
  
Very difficult Difficult Easy Very easy 
1 2 3 4 
 
9. How easy was it for you to keep a clear picture of this situation in your head? 
  
Very difficult Difficult Easy Very easy 
1 2 3 4 
  
10. Remind me of what happened in this situation. 
(Underline each element that the patient is able to recall without prompting.) 
 
It’s 7.30am and you have had a poor sleep / A nurse wakens you and abruptly says it’s time to get up and puts your 
light on /  He tells you to make your bed and have a shower  / You’re still lying in bed when / another member of staff  
comes by / and insists that you get up for a shower straight away.  Score =  
 188 
 
IMAGINAL PROVOCATION TEST (IPT) 
Name ……………………………………………  Group …………………..     Date …………………… 
SCENE D 
You see a bully approaching a vulnerable patient. He demands some tobacco that the patient got from a family visitor. 
The patient looks confused and worried. The bully grabs him by the arm, threatens him and gets the tobacco. The 
bully walks away smirking. 
 
1. How angry does this make you feel? 
  
Not at all A little Fairly Very 
1 2 3 4 
 
If this happened to you: 
 
2. You would swear or shout. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
3. You would want to hit the person. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
4. You would stay calm and cool. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
5. You would want to smash or kick something. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
6. You would want to tell the person off and start an argument. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
7. You would try to understand why the person did this and not get angry about it. 
  
Not at all A little Quite a bit A lot 
1 2 3 4 
 
8. How easy was it for you to imagine (see yourself) in this situation? 
  
Very difficult Difficult Easy Very easy 
1 2 3 4 
 
9. How easy was it for you to keep a clear picture of this situation in your head? 
  
Very difficult Difficult Easy Very easy 
1 2 3 4 
  
10. Remind me of what happened in this situation. 
(Underline each element that the patient is able to recall without prompting.) 
You see a bully approaching a vulnerable patient/ He demands some tobacco that the patient got from a family visitor 
/ The patient looks confused and worried / The bully grabs him by the arm, threatens him and gets the tobacco / The 











































By Dr. Reuven Bar-On 
Introduction 
 
EQ-i® consists of statements that provide you with an opportunity to describe 
yourself by indicating the degree to which each statement is true of the way you 
feel, think or act most of the time and in most situations. There are five possible 
responses to each sentence: 
 
1. Very seldom or Not true of me 
2. Seldom true of me 
3. Sometimes true of me 
4. Often true of me 
5. Very often true of me or True of me 
Instructions 
 
Read each statement and decide which one of the five possibilities best 
describes you. Mark your choices on the answer sheet by filling in the circle 
containing the number that corresponds to your answer. 
 
If a statement does not apply to you, respond in such a way that will give the 
best indication of how you would possible feel, think, or act. Although some of 
the sentences may not give you all the information you would like to receive, 
choose the response that seems the best, even if you are not sure. There are no 
“right” or “wrong” answers and no “good” or “bad” choices. Answer openly and 
honestly by indicating how you actually are and not how you would like to be or 
how you would like to be seen. There is no time limit, but work quickly and make 
sure that you consider and respond to every statement. 
 
1 My approach in overcoming difficulties is to move step by step. 1 2 3 4 5 
2 It’s hard for me to enjoy life. 1 2 3 4 5 
3 I prefer a job in which I’m told pretty much what to do. 1 2 3 4 5 
       
4 I know how to deal with upsetting problems. 1 2 3 4 5 
5 I like everyone I meet. 1 2 3 4 5 
6 I try to make my life as meaningful as possible 1 2 3 4 5 
       
7 It’s fairly easy for me to express feelings. 1 2 3 4 5 
8 I try to see things as they really are, without fantasizing or 
daydreaming about them. 
1 2 3 4 5 
9 I’m in touch with my emotions. 1 2 3 4 5 
       
10 I’m unable to show affection. 1 2 3 4 5 
11 I feel sure of myself in most situations. 1 2 3 4 5 
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12 I have a feeling that something is wrong with my mind. 1 2 3 4 5 
       
13 It is a problem controlling my anger. 1 2 3 4 5 
14 It’s difficult for me to begin new things 1 2 3 4 5 
15 When faced with a difficult situation, I like to collect all the 
information about it that I can. 
1 2 3 4 5 
16 I like helping people 1 2 3 4 5 
17 It’s hard for me to smile. 1 2 3 4 5 
18 I’m unable to understand the way other people feel. 1 2 3 4 5 
       
19 When working with others, I tend to rely more on their ideas 
than my own. 
1 2 3 4 5 
       
20 I believe that I can stay on top of tough situations. 1 2 3 4 5 
21 I really don’t know what I’m good at. 1 2 3 4 5 
22 I’m unable to express my ideas to others. 1 2 3 4 5 
       
23 It’s hard for me to share my deep feelings with others. 1 2 3 4 5 
24 I lack self-confidence. 1 2 3 4 5 
25 I think I’ve lost my mind. 1 2 3 4 5 
       
26 I’m optimistic about most things I do. 1 2 3 4 5 
27 When I start talking, it is hard to stop. 1 2 3 4 5 
28 It’s hard for me to make adjustments in general. 1 2 3 4 5 
       
29 I like to get an overview of a problem before trying to solve it. 1 2 3 4 5 
30 It doesn’t bother me to take advantage of people, especially if 
they deserve it. 
1 2 3 4 5 
31 I’m a fairly cheerful person. 1 2 3 4 5 
       
32 I prefer others to make decisions for me. 1 2 3 4 5 
33 I can handle stress, without getting too nervous. 1 2 3 4 5 
34 I have good thoughts about everyone. 1 2 3 4 5 
       
35 It’s hard for me to understand the way I feel. 1 2 3 4 5 
36 In the past few years, I’ve accomplished little. 1 2 3 4 5 
37 When I’m angry with others, I can tell them about it. 1 2 3 4 5 
       
38 I have had strange experiences that can’t be explained. 1 2 3 4 5 
       
39 It’s easy for me to make friends. 1 2 3 4 5 
40 I have a good self-respect. 1 2 3 4 5 
41 I do very weird things. 1 2 3 4 5 
       
42 My impulsiveness creates problems. 1 2 3 4 5 
43 It’s difficult for me to change my opinion about things. 1 2 3 4 5 
44 I’m good at understanding the way other people feel. 1 2 3 4 5 
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45 When facing a problem, the first thing I do is stop and think. 1 2 3 4 5 
46 Others find it hard to depend on me. 1 2 3 4 5 
47 I am satisfied with my life. 1 2 3 4 5 
       
48 It’s hard for me to make decisions on my own. 1 2 3 4 5 
49 I don’t hold up well under stress. 1 2 3 4 5 
50 I don’t do anything bad in my life. 1 2 3 4 5 
       
51 I don’t get enjoyment from what I do. 1 2 3 4 5 
52 It’s hard to express my intimate feelings. 1 2 3 4 5 
53 People don’t understand the way I think. 1 2 3 4 5 
54 I generally hope for the best. 1 2 3 4 5 
55 My friends can tell me intimate things about themselves. 1 2 3 4 5 
56 I don’t feel good about myself. 1 2 3 4 5 
       
57 I see these strange things that others don’t see. 1 2 3 4 5 
       
58 People tell me to lower my voice in discussions. 1 2 3 4 5 
59 It’s easy for me to adjust to new conditions. 1 2 3 4 5 
60 When trying to solve a problem, I look at each possibility and 
then decide on the best way. 
1 2 3 4 5 
       
61 I would stop and help a crying child find his or her parents, 
even if I had to be somewhere else at the same time. 
1 2 3 4 5 
62 I’m fun to be with. 1 2 3 4 5 
63 I’m aware of the way I feel. 1 2 3 4 5 
       
64 I feel that it’s hard for me to control my anxiety. 1 2 3 4 5 
65 Nothing disturbs me. 1 2 3 4 5 
66 I don’t get that excited about my interests. 1 2 3 4 5 
       
67 When I disagree with someone, I’m able to say so. 1 2 3 4 5 
68 I tend to fade out and lose contact with what happens around 
me. 
1 2 3 4 5 
69 I don’t get along well with others. 1 2 3 4 5 
       
70 It’s hard for me to accept myself just the way I am. 1 2 3 4 5 
71 I feel cut off from my body. 1 2 3 4 5 
72 I care what happens to other people. 1 2 3 4 5 
       
73 I’m impatient. 1 2 3 4 5 
74 I’m able to change old habits. 1 2 3 4 5 
75 It’s hard for me to decide on the best solution when solving 
problems. 
1 2 3 4 5 
       
76 If I could get away with breaking the law in certain situations, I 1 2 3 4 5 
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would. 
       
77 I get depressed. 1 2 3 4 5 
78 I know how to keep calm in difficult situations. 1 2 3 4 5 
79 I have not told a lie in my life. 1 2 3 4 5 
       
80 I’m generally motivated to continue, even when things get 
difficult. 
1 2 3 4 5 
81 I try to continue and develop those things that I enjoy. 1 2 3 4 5 
82 It’s hard for me to say “no” when I want to. 1 2 3 4 5 
       
83 I get carried away with my imagination and fantasies. 1 2 3 4 5 
84 My close relationships mean a lot to me and to my friends. 1 2 3 4 5 
85 I’m happy with the type of person I am. 1 2 3 4 5 
       
86 I have strong impulses that are hard to control. 1 2 3 4 5 
87 It’s generally hard for me to make changes in my daily life. 1 2 3 4 5 
88 Even when upset, I’m aware of what’s happening to me. 1 2 3 4 5 




In handling situations that arise, I try to think of as many 











90 I’m able to respect others. 1 2 3 4 5 
91 I’m not that happy with my life. 1 2 3 4 5 
       
92 I’m more of a follower than a leader. 1 2 3 4 5 
93 It’s hard for me to face unpleasant things. 1 2 3 4 5 
94 I have not broken a law of any kind. 1 2 3 4 5 
       
95 I enjoy those things that interest me. 1 2 3 4 5 
       
96 It’s fairly easy for me to tell people what I think. 1 2 3 4 5 
97 I tend to exaggerate. 1 2 3 4 5 
98 I’m sensitive to the feelings of others. 1 2 3 4 5 
       
99 I have good relations with others. 1 2 3 4 5 
100 I feel comfortable with my body. 1 2 3 4 5 
101 I am a very strange person. 1 2 3 4 5 
       
102 I’m impulsive. 1 2 3 4 5 
103 It’s hard for me to change my ways. 1 2 3 4 5 
104 I think it’s important to be a law-abiding citizen. 1 2 3 4 5 
       
105 I enjoy weekends and holidays. 1 2 3 4 5 
106 I generally expect things will turn out all right, despite setbacks 
from time to time. 
1 2 3 4 5 
107 I tend to cling to others. 1 2 3 4 5 
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108 I believe in my ability to handle most upsetting problems. 1 2 3 4 5 
109 I have not been embarrassed for anything that I’ve done. 1 2 3 4 5 
110 I try to get as much as I can out of those things that I enjoy. 1 2 3 4 5 
       
111 Others think that I lack assertiveness. 1 2 3 4 5 
112 I can easily pull out of daydreams and tune into the reality of 
the immediate situation. 
1 2 3 4 5 
113 People think that I’m sociable. 1 2 3 4 5 
       
114 I’m happy with the way I look. 1 2 3 4 5 
       
115 I have strange thoughts that no one can understand. 1 2 3 4 5 
116 It’s hard for me to describe my feelings. 1 2 3 4 5 
117 I’ve got a bad temper. 1 2 3 4 5 
       
118 I generally get stuck when thinking about different ways of 
solving problems. 
1 2 3 4 5 
119 It’s hard for me to see people suffer. 1 2 3 4 5 
120 I like to have fun. 1 2 3 4 5 
       
121 I seem to need other people more than they need me. 1 2 3 4 5 
122 I get anxious. 1 2 3 4 5 
123 I don’t have bad days. 1 2 3 4 5 















125 I don’t have a good idea of what I want to do in life. 1 2 3 4 5 
126 It’s difficult for me to stand up for my rights. 1 2 3 4 5 
       
127 It’s hard for me to keep things in the right perspective. 1 2 3 4 5 
128 I don’t keep in touch with friends. 1 2 3 4 5 
129 Looking at both by good points and bad points, I feel good 
about myself. 
1 2 3 4 5 
       
130 I tend to explode with anger easily. 1 2 3 4 5 
131 It would be hard for me to adjust if I were forced to leave my 
home. 
1 2 3 4 5 
132 Before beginning something new, I usually feel that I will fail. 1 2 3 4 5 
       
133 I responded openly and honestly to the above sentences. 1 2 3 4 5 
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